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ABSTRACT 
Sugar intake is linked to developmental programming of obesity and diabetes. We 
hypothesized that supplementing ground beef in place of sugar during pregnancy would reduce 
fetal and offspring developmental programming. Gestating sows were fed 1 of 4 isocaloric 
supplements: control, ground beef, granulated sugar, or beef plus sugar. In the fetal study 
supplements were fed from d 40 to 110 of gestation and in the offspring study from d 40 until 
weaning. Gene expression differences in fetal liver and muscle were observed for IGF2 (P = 
0.04), FBPase (P = 0.03), and IGF2R (P = 0.02). Differences were also seen in offspring back 
fat (sex by day interaction, P = 0.01), longissimus dorsi muscle area (treatment by sex, P = 
0.001), body weight (sex, P = 0.0006; sex by day interaction, P < 0.0001), and plasma insulin 
concentrations (treatment by sex, P = 0.0002). 
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CHAPTER 1: LITERATURE REVIEW 
Biomedical Models 
History of Biomedical Models 
Animals have been used to understand human anatomy and physiology throughout 
history, helping scientists truly understand how the body works (Franco, 2013). Using animals as 
models for human medicine has been seen as early as 4th century BCE, with Aristotle and 
Erasistratus preforming experiments on living animals (Hajar, 2011; Franco, 2013).  
As progression of science continued into the 17th century so did the physiological 
experiments being conducted on animals. In 1628, William Harvey published groundbreaking 
work explaining in great detail the description of blood circulation and the functions of the heart 
(Ribatti, 2009; Franco, 2013). During the 17th century, it was originally thought that organs 
absorbed blood, the liver was thought to produce new blood based on the nutrients a person 
would eat, and the heart had a heating function over a pumping mechanism (Franco, 2013). 
Harvey used multiple animal models such as fish, reptiles, birds, and mammals to understand 
that the heart was responsible for moving blood around via muscle contraction (Ribatti, 2009). 
With the new understanding of the heart, animal models in the 17th century were now proving to 
be more informative for obtaining scientific knowledge on biological processes compared to 
previous years (Franco, 2013).  
When looking at scientific advancements of the 18th century, one of the early 
breakthroughs was the discovery of how to measure blood pressure (Smith, 1993).  In 1707 
Stephen Hales began to measure the pressure in the leg and neck vessels of dogs. He continued 
this research over many decades, examining other animals such as horses, ox, and sheep (Smith, 
1993). As Hales was making remarkable discoveries in the cardiovascular area other scientists 
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continued to use animal models to improve the knowledge of experimental pharmacology, 
electrophysiology, and modern embryology (Franco, 2013). Even with the scientific 
advancements being made in the 18th century, one aspect that had still yet to be developed was 
anesthesia, meaning all the discoveries being made were generally on live animals (Nuffield 
Council on Bioethics, 2005). As research continued the public started to focus on animal 
suffering causing many individuals to join antivivisection groups to protest the use of animals. 
Most felt that if humans allowed animals to suffer that it would cause humans to become corrupt, 
causing them to not have limits on what researchers were willing to do to animals in the name of 
science (Nuffield Council on Bioethics, 2005). Physiologists of this time disagreed with their 
antivivisection counterparts, stating that medical advancements could be made through 
knowledge gained from animal experimentation (Maehle, 1990; Franco, 2013). These thoughts 
of 18th century researchers would further be used by 19th century physicians to justify the use of 
animals (Maehle, 1990; Franco, 2013).  
As animal research continued into the 19th century, the medical community was also 
evolving. Louis Pasteur conducted experiments on animal models to develop antiseptic 
techniques and properly disinfect surgical instruments (Franco, 2013). Pasteur heavily advocated 
that laboratory practices should be used in medical procedures, even stating that after washing 
his hands with great care he wishes he could heat them like his instruments (Schlich, 2012).  
During the second half of the 19th century Emil Behring and Shibasaburo Kitasato discovered the 
antitoxin for diphtheria (Kaufmann, 2017). This was accomplished by using horses for 
immunization and reducing the normally fatal outcome of diphtheria (Kaufmann, 2017). As 
antitoxins were being made for human medical practices, Behring and Kitasato first isolated 
serum from sheep, but concluded that horse serum was better equipped for their antitoxins 
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(Kaufmann, 2017). With the development of antitoxins and vaccines during the 19th century, 
dramatic increases in animal-based research were seen in the following century.  
Increases in education during the 19th century allowed the 20th century to explode with 
scientific discoveries. During the 20th century major medical advancements were made, from the 
discovery of vitamins, hormones, and antibiotics to the eradication of small pox (Franco, 2013). 
With these scientific discoveries, more animal models were being used to continue research, 
which brought backlash during the beginning of the century. During this time, researchers started 
using mice and rats for their animal experiments (Franco, 2013; Sengupta, 2013). There were 
multiple reasons to transition research to rodent species; they were easy to handle and house, 
opposition to their use was less since most people saw them as a pest, and they exhibited similar 
physiological systems to humans (Franco, 2013; Sengupta, 2013; PerLDMAn, 2016). In 1980, as 
research continued with mice, John Gordon and Frank Ruddle (1981) developed the first 
transgenic mouse. This novel technique opened the door to new information about gene 
regulation in higher eukaryotes (Gordon et al., 1981).  
As the United States Department of Agriculture (USDA) grew, in 1971 it began requiring 
individual research facilities to report their current number of animals for experimentation 
(Kulpa-Eddy et al., 2007). This requirement put into numbers how many animals were being 
used for research, but this did not include mice, rats, or fish (Kupla-Eddy et al., 2007). Even with 
no official report on numbers, mice, and rats continued to dominate animal models into the 21st 
century, while some researchers continued to use different animals for their research, such as 
cats, dogs, pigs, sheep, and other livestock (Ericsson et al., 2013). Generally, when farm animals 
were used for research it was in the areas of growth performance, feed efficiency, lactation, and 
reproduction (Wolf et al., 2000). As animal models continued to be used in research and new 
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genetic advancements were made, scientists could use more humanized models, such as swine, to 
continue research of diseases mouse models are not able to properly replicate (Ericsson et al., 
2013).  
Swine as a Biomedical Model 
Swine were first domesticated around 8000 years ago. During this time and even until 
recent years pigs have been mainly used to provide meat as a main protein source in some 
culture’s diets (Gutierrez et al., 2015). In more recent years swine are still primarily used as a 
food source, but their practicality for preclinical research is also valuable (Kobayashi et al., 
2012). Rodents currently dominate the animal models used in biomedical research. Koopmans 
and Schuurman (2015) reported that in Europe almost 80% of the mammals being used for 
biomedical research were rodents. The remaining 20% was split between rabbits and swine 
models (Koopmans and Schuumran, 2015). Even with rodents being the most commonly used 
species, they often are not able to show an accurate representation of how human diseases 
progress (Koopmans and Schuumran, 2015). Use of swine has continuously increased in the 
biomedical field because of their similar anatomy, physiology and disease progression to humans 
(Lunney, 2007).  Along with having similar anatomy and physiology to humans, pigs are also 
considered omnivores and have a high motivation for food intake and food choice; therefore, this 
allows pigs to be excellent models for nutrient absorption, intestinal transport, and 
gastrointestinal disease studies (Aigner et al., 2010; Gutierrez et al., 2015; Koopmans et al., 
2015). Not only have swine been used for nutritional research but they are also used a variety of 
different medical fields to help advance scientific understanding. Swine have been used in 
wound and dermal studies, oncology, surgical training, cystic fibrosis, along with metabolic 
syndrome, diabetes, and obesity (Lunney, 2007; Aigner et al., 2010; Gutierrez et al., 2015).  
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Using swine as a model for human medicine can be separated into different categories 
based on the size of the animal. The first is domestic pigs, which are normally seen in 
production, as models usually having a mature body weight of over 100 kg (Kobayashi et al., 
2012). The main reasons for using domestic pigs is because they are easy to obtain from local 
farmers and tend to cost less. One of the main tools domestic swine provide is the practice of 
surgical skill in schools, these pigs tend to have similar sized anatomy compared to humans, 
which helps improve students’ skills (Kobayashi et al., 2012).  The second category swine could 
fall into is miniature pigs. Miniature pigs tend to be smaller in size, approximately 45 kg, which 
allows them to be easier to handle (Kobayashi et al., 2012). A down side to using minipigs is that 
they are more expensive but for some researchers their small stature out weights the price. 
Miniature pigs are used in a variety of research including diabetes, obesity, and metabolic 
problems due to their similar metabolism and propensity to becoming obese, letting researches 
study diet induced issues (Xi et al., 2004; Larsen et al., 2012; Christoffersen et al., 2012). The 
third and last category is considered micropigs, which are smaller in size compared to minipigs 
and are generally used for preclinical safety evaluations (Kobayashi et al., 2012). Micropigs were 
bred by the Medi Kinetics breeding program for biomedical research, they offer different 
genetics and physiological characteristics from minipigs and domestic pigs, and allow for 
different research to be conducted (Kim et al., 2013). Micropigs used from Medi Kinetics can be 
found in four different types; ET-type, T-type, M-type, and L-type with the major difference 
between the four types of micropigs are their size. These four different types of micro pigs they 
tend to range in size from 18 kg to 37 kg at one year of age, making them easier for researchers 
to handle (Medi Kinetics).  
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There are several ways in which swine are used as research models. The first is to study 
their physiological responses to treatment, such as the effects of feeding a diet high in fats or 
sugars on metabolism (Xi et al., 2004; Bendixen et al., 2018). A second type of study is an 
induced model. In these models a specific foreign body is introduced, triggering a response that 
would not normally occur (Bendixen et al., 2018). An example of this is when a dopaminergic 
neurotoxin can induce parkinsonians in swine (Bendixen et al., 2018). A third and final is 
transgenic models, with these models a gene not normally present in swine is transferred into the 
swine genome, causing the disease associated with this gene to be expressed (Bendixen et al., 
2018). An example of a transgenic model is swine that have been able to replicate the disease 
progression of cystic fibrosis (Stoltz et al., 2010; Gün et al., 2014). This model is generated when 
the mutated gene encoding the cystic fibrosis transmembrane conductance regulator (CFTR) 
anion channel was introduced to swine, creating a model that showed the progression of the 
disease (Stoltz et al., 2010).  
Using Swine in Diabetes, Obesity, and Metabolic Research 
When using swine as models for human disease, some of the most commonly studied 
conditions are diabetes, obesity, and metabolic syndrome. It is understood and recognized that 
there is not direct numerical value equivalent between animals and humans, but because pigs 
have such similar anatomy and physiology to humans it makes translating the information 
possible (Larsen et al., 2002; Litten-Brown et al., 2010).  
According to the World Health Organization (2017), the incidence of diabetes has 
drastically risen from 4.7 % to 8.5 % in 35 years, causing concerns for our global health status. 
Diabetes is defined as a chronic disease when the pancreas does not produce enough insulin or 
that the body cannot effectively use insulin, resulting in a loss of control of blood glucose levels 
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(WHO, 2017; Perleberg et al., 2018). When studying diabetes in swine a feed induced study is 
often used to model the response to typical American diets. Xi et al. (2004) reported that 
minipigs fed a high-fat/high sucrose diet did develop induced diabetes. Researchers also 
performed an oral glucose tolerance test and saw that pigs fed the high-fat/high sugar diet had 
significantly greater (P < 0.0001) plasma glucose levels then the control group (Xi et al., 2004). 
This study supports current information from the WHO (2017), showing that diet plays a major 
role into the increase of diabetes worldwide.  
Obesity is also commonly studied using pigs as models. The WHO (2018) defines 
overweight and obesity as abnormal or excessive fat accumulation that may impair health. While 
diabetes can be measured using plasma glucose levels, obesity is generally measured using the 
body mass index (BMI). This is a measure of body weight relative to height (WHO, 2018).  This 
is a valuable tool to measure population-levels of obesity, but a downfall is it does not take into 
account muscle mass versus fat mass, which can inaccurately categorize lean, muscular people as 
overweight or obese. A study conducted by Christoffersen et al. (2012), saw that feeding 
Göttingen minipigs a diet high in energy caused the pigs in the treatment group to increase their 
weight 40% more than the low energy diet control group. Researchers also saw an increase in fat 
deposition in the high-energy diet, which was measured at the beginning of the study using a 
dual energy X-ray absorptiometry scanning, and then collected at euthanasia (Christoffersen et 
al., 2012). This study also helps show that diet is a major player in overall health of an 
individual.  
Lastly metabolic syndrome is also frequently studied using swine as models. Metabolic 
syndrome is the interconnection of physiological, biochemical, clinical and metabolic factors that 
cause an increased risk to cardiovascular disease, diabetes mellitus and overall mortality (Kaur, 
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2014). Metabolic syndrome causes a variety of symptoms that other diseases such as diabetes 
and obesity also show, such as insulin resistance, and visceral adiposity, causing these three 
diseases to be heavily connected (Kaur, 2014). A study conducted by Ma et al. (2016) fed swine 
a high-fat/high-fructose diet to determine its effects on renal function. From this study 
researchers were able to determine that the pigs eating the high-fat/high-fructose diet have 
metabolic syndrome from basic characteristic of the disease, such as obesity, increased fat 
depots, hypertension, and insulin resistance (Ma et al., 2016). Researchers also determined that 
due to the increase in perineal fat depots it caused impairments in renal arterial endothelial 
function (Ma et al., 2016).    
Maternal Nutrition 
Times of famine have been seen throughout history, since the foundation of modern 
agriculture practices (Vorstenbosch et al., 2017). Famine has occurred all around the globe from 
the Chinese famine (1959-1961) to the Nigerian famine (1967-1970), and the Dutch hunger 
winter, which lasted from November 1944 to May of 1945 (Vaiseman, 2017). The Dutch famine 
is one of the most in depth studied famines, because it was so short and severe, and had a 
population that was already well-nourished and it gave researcher’s the opportunity to examine 
how mother’s nutrition during different stages of pregnancy affect the offspring immediately 
after birth along with years later into adult life (Roseboom et al., 2006; Vaiseman, 2017). Hart 
(1993) stated that a healthy infant can only be made within the body of a healthy mother, with 
this statement by Hart it sparks the question, what is a healthy mother? The Dutch famine was 
just one of the stepping stones to answer this question. 
 9 
History of the Dutch Hunger Winter 
The Dutch famine began in November of 1944 though the events that led up to this event 
occurred in the months before. In June the Allied forces started to break through German lines 
and by September they had reached the Netherlands (Roseboom et al., 2006). To support the 
Allied forces the Dutch government called for a strike on the railroad, which caused the Germans 
to ban all food transports, including via railroad or water. Though this was lifted in November of 
1944, by this time a harsh winter had set in freezing all access leading to widespread food 
shortages and famine (Roseboom et al., 2006). Caloric intake started to decrease in October 
1944, eventually dropping to 400 calories per day from the previous 1800 calories that most of 
the population received in December of 1943 (Banning, 1946; Roseboom, 2006). During 
November of 1944 caloric intake dropped below 1000 calories, once again in December of 1944 
through April of 1945 caloric intake was estimated between 400 and 800 per person/day 
(Banning, 1946; Roseboom et al., 2006). The Netherlands were liberated in May 1945 and their 
food supply swiftly increased in June 1945 to more than 2000 calories per person/day 
(Roseboom et al., 2006).  
Dutch Hunger Winter Effects on Obesity, Diabetes, and Glucose Tolerance Test   
Obesity has been studied in many ways, one that has always been of interest to 
researchers is what influences an individual’s risks to become obese later in life (Rolland-
Cachera et al., 2016). It has been determined that fetal life is a critical period for the development 
of obesity later in life, and that there is a relationship between birthweight, BMI in childhood and 
in adult life (Ravelli et al., 1999; Simmons, 2008). A study conducted by Ravelli et al. (1999) 
examined birth records during the Dutch famine, to determine if famine exposer during gestation 
affected an individual’s chance of becoming obese later in life. To help determine if famine 
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exposure did have an effect, researcher’s contacted individuals born the year before and after the 
famine, along with babies born during the famine (Ravelli et al., 1999). From this study 
researcher’s determined that exposure to the Dutch famine in early gestation resulted in higher 
body weights, BMI and waist circumference in women but not men at the age of 50. From these 
results it was stated that poor maternal diet in early gestation was linked to an increase of obesity 
in middle aged women (Ravelli et al., 1999). Another study conducted by Lumey et al. (2009), 
also reported an association between undernutrition in pregnancy and an increase in blood lipid 
profiles of women at age 58 that were exposed during the Dutch Famine. This is just two of the 
many human studies demonstrating that in utero nutrition plays a role in programming of 
obesity.  
Along with obesity being studied as an effect of the Dutch hunger famine, diabetes is also 
heavily studied due to the link between thinness at birth and developing insulin resistance later in 
life (Taylor et al., 1995; Eriksson et al., 2003). Low birth weight has also been associated with 
metabolic syndrome, which is the co-existence of hypertension, glucose intolerance, 
hypertriglyceridemia, and insulin resistance (Taylor et al., 1995).  A study conducted by Ozanne 
et al. (2005), sought to determine if early growth restriction during gestation is associated with 
the same molecular fingerprint in the insulin-signaling pathway as in animal models. To conduct 
this study, forearm muscle biopsy samples were taken from 40 men, 20 with birthweights below 
average and 20 with birthweights above average, that were born in 1980 (Ozanne et al., 2005). 
From this study there was no differences in insulin receptor expression. This observation was 
consistent with other studies suggesting the molecular defect for insulin resistance was not as a 
result of the insulin receptor, but rather something farther downstream in the signaling pathway 
(Krook et al., 2000; Ozanne et al., 2005). Differences were seen in expression of PCK, p85α, 
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p110β, and GLUT4, and similar expression was seen in in PCK, and p85α, in the muscle of 
diabetic patients (Goodyear et al., 1995; Farese, 2002; Ozanne et al., 2005). Subjects from this 
study were in their early 20’s when conducted, the information form this study could be used as a 
predictor on which subjects may develop diabetes later in life based on individual gene 
expression.  
As previously discussed, people with small birth weights have an increased risk of 
diabetes later in life (de Rooij et al., 2006). One way to determine diabetes in an individual and 
possibly predict insulin resistance later in life is by conducting a glucose tolerance test. It has 
been reported in many animal studies that the impairment of glucose tolerance is caused by 
insulin secretion defects where nutrient supplies do not meet the demand of that individual, 
generally due to permanent alterations in structure and function of pancreatic β-cells made by the 
fetus (de Rooji et al., 2006). These alterations can be seen in intrauterine environments that have 
an over nutrition, causing β-cell hyperplasia in the fetus, while in undernutrition environments 
seeing a reduction in β-cell mass (Hales et al., 1991). de Rooji et al. (2006) performed an oral 
glucose tolerance test on 699 individuals that were exposed to the Dutch famine during gestation. 
From this study they saw that glucose concentrations were higher at 120 min after glucose 
among individuals that were exposed to the famine compared to individuals that were not 
exposed (de Rooji et al., 2006). They also reported that as birth weight, birth length and birth 
head circumference decrease, there was an increase insulin concentration at 120-minute (de 
Rooji et al., 2006). From these finding researchers determined that there was an association 
between undernutrition during gestation and reduced glucose tolerance and elevated circulating 
insulin concentrations, it was also noted that glucose and insulin concentrations were higher in 
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individuals exposed to famine in any stage of gestation compared to individuals that were not 
exposed (de Rooji et al., 2006). 
Over Nutrition in the United States 
Americans consume an average of 71.14 g of added sugar that leads to health issues such 
as diabetes and obesity (CDP, 2016; ODPHP, 2016). The incidence of diabetes has jumped from 
4.7% in 1980 to 8.5% in 2014, while overweight and obese individuals are at approximately 39% 
and 13% of the world’s population respectively (WHO, 2017; WHO, 2018). The increase of 
these diseases is thought to occur at least partly because of mother diets during pregnancy, 
specifically looking at a mother’s diet that is high in either sugar or fat, causing them to 
accumulate fat storages in the body (Li et al., 2011). This idea that over nutrition during 
pregnancy causes diabetes, obesity, and other metabolic diseases has been shown multiple times 
in rat and sheep studies (Li et al., 2011). This has led to an interest in research to determine what 
maternal diets will provide offspring with the best chance of not developing one of these diseases 
later in life.  
Over Nutrition Effects on Obesity, Diabetes, and Glucose Tolerance Test 
Obesity is generally referred to a disease that is induced by diet and lifestyle (Breier et 
al., 2001). Obesity and other related metabolic disorders are thought to be caused by high intake 
of processed or ‘junk foods’ that contain high amount calories, fats, or sugars (Breier et al., 2001; 
Bayol et al. 2005).  In recent years obesity has been categorized as a global epidemic, 
significantly impacting the quality of life in individuals (Taylor and Poston, 2007). Previously, 
researchers focused on maternal undernutrition but as countries have developed only a 
percentage of the population is considered underfeed due to the abundance of food, switching 
researchers to focus on maternal over nutrition (Bayol et al., 2005). Two studies conducted by 
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Bayol et al. (2005; 2007) fed a normal rat chow or a cafeteria diet, which contained palatable 
foods high in fats and sugars, to pregnant rats to determine if fat deposition increased in the 
offspring of the cafeteria diet-fed dams. They observed that offspring from mothers fed the 
cafeteria diet had increased birth weights compared to the control diets. The cafeteria-treatment 
offspring also exhibited muscle atrophy, intramuscular fat accumulation, and an overall increase 
in adipose tissue weight (Bayol et al., 2005; Bayol et al., 2007). 
As previously mentioned, maternal diet during pregnancy is an interest to researcher’s 
due to not fully understanding the effects of either over/under nutrition. One of the more recent 
views is that adult diseases, such as diabetes, are being initiated by over nutrition while in utero 
(Barker, 2007). It has been reported by Maric-Bilkan et al. (2011), that maternal body weight, 
over nutrition, or high fat consumption during pregnancy influences offspring’s risk of 
developing metabolic syndrome, cardiovascular and renal disease, hypertension, diabetes, and 
obesity. It should also be noted that because of the increased prevalence of diabetes, more 
women of child bearing age are affected by diabetes during their pregnancy, which could 
increase the risk of their offspring developing this condition later in life (Maric-Bilkan et al., 
2011). A study conducted by Dabelea and Pettitt (2001), investigated the age at which diabetes 
developed in offspring of mothers who were diabetic, pre-diabetic, and nondiabetic. From this 
study they concluded that offspring born to mothers who had diabetes were more likely to 
develop diabetes compared to mothers who were pre-diabetic or nondiabetic (Dabelae and 
Pettitt, 2001). Birth weight is also a risk factor for developing diabetes later in life. It has been 
noted that either low (thinness) or high birth weights are associated with increased rates of 
obesity and diabetes later in life (Taylor et al., 1995; Barker, 2007). A study conducted by Rich-
Edwards et al. (1999) examined how birthweight is associated with increased risk of diabetes 
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later in life. From this study, researchers discovered that there was an inverse correlation 
between birthweight and diabetes. Individuals that weighed less than 5 lbs or greater than 10 lbs 
at birth had a higher risk for developing diabetes compared to individuals that were to 7.1-8.5 lbs 
at birth (Rich-Edwards et al., 1999).   
Maternal obesity is becoming more of an issue in developed countries, which then leads 
to an increased likelihood that offspring of these individuals may develop obesity, insulin 
resistance, and impaired glucose tolerance (Rajia et al., 2010). Slight insulin resistance is 
considered normal during pregnancy due to the body adapting to provide direct nutrients to the 
fetus (George et al., 2010). Insulin resistance becomes an issue when the body is not able to 
maintain normal blood glucose concentrations. Insulin resistance can cause hyperinsulinemia, 
hyperglycemia, and eventual gestational diabetes, which can harm the mother and fetus (George 
et al., 2010). Samuelsson et al. (2008) fed pregnant rats a normal chow diet or a cafeteria diet 
that was high in fats and sugars to see the effects on blood glucose levels of the offspring at 3 
and 6 months of age. Using a glucose tolerance test, researchers saw that there was abnormal 
levels of glucose at both 3 and 6 months of age in the cafeteria diet compared to the chow diet 
indicating that glucose intolerance was present in these animals (Samuelsson et al., 2008).  
Material Nutrition and Developmental Programming  
During pregnancy, fetuses are prone to being affected by either under- or over-nutrition, 
studying the Dutch hunger famine has shown that maternal undernutrition during gestation has a 
lasting effect on the offspring (Roseboom et al., 2011). It has also been shown that mother’s 
nutrition during gestation, specifically early gestation, plays a role in the composition of the 
individual’s epigenetic patterns (Waterland et al., 2003; Geraghty et al., 2015). Epigenetics refers 
to an individual’s genes that can alter gene expression, without changing the DNA sequence 
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(Geraghty et al., 2015). It has also been noted that persistent epigenetic changes that are induced 
by environmental factors playing a role in the underlying relationship between early 
development and disease later in life (Tobi et al., 2009). A study conducted by Tobi et al. (2009), 
examined individuals that were exposed to the Dutch hunger famine in utero, specifically 
looking at the methylation of 15 genes for metabolic disease. From this study they were able to 
see that adverse prenatal environment may trigger changes in the DNA methylation, specifically 
showing that insulin-like growth factor 2 receptor (IGF2R) was higher in men, while leptin 
(LEP) was lower in men exposed to famine causing researchers to dive deeper into studying 
DNA methylation and the relationship with an individual’s development later in life (Tobi et al., 
2009).  
Genes Affecting Diabetes and Obesity  
Maternal diet can impact both phenotype and long-term development of a fetus (Fleming 
et al., 2004). When environmental stressors are present they can cause a shift in gene expression 
of the fetus, causing growth-regulating genes to become susceptible to change (Fleming et al., 
2004). Looking specifically at genes related to obesity and diabetes, insulin resistance is a main 
characterization with defects arising from many levels (Saltiel et al., 2001). Genetics and 
environmental factors play major roles in the influence of insulin sensitivity (Saltiel et al., 2001).  
Multiple animal studies have shown environmental influences that produce changes in epigenetic 
marks, resulting in life-long consequences (Heijmans et al., 2008).  
Diabetes and Metabolism  
Glycogen is needed for both animals and humans to survive and must be present in 
adequate amounts (Danforth, 1964). If the body does not have the proper amount of glycogen 
needed for daily maintenance, metabolic issues can start to develop. Under normal physiological 
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conditions insulin stimulates skeletal muscle to take up glucose where it is metabolized either by 
oxidative or nonoxidative pathways (Thorburn et al., 1990). In the case of non-insulin-dependent 
diabetes mellitus, glucose uptake is impaired, causing glucose disposal issues in skeletal muscle 
(Thorburn et al., 1991). Within skeletal muscle, glycogen synthesis is needed for blood glucose 
homeostasis. Azpiazu et al., (2000) reported that when there was an overexpression of glycogen 
synthase 1 (GYS1) there was an increase in glycogen accumulation in the muscles causing a shift 
in homeostasis. In another study conducted by Xirouchaki et al., (2016) researcher’s used GYS1 
knockout mice to determine the role of GYS1 on glucose metabolism. From this study 
researchers were able to determine that the GYS1 knockout mice had hyperglycemia and 
hyperinsulinemia, indicating impaired glucose metabolism under non-fasting conditions and 
confirming that GYS1 plays a role in insulin sensitivity and glucose uptake (Xirouchaki et al., 
2016). 
 
Figure 1.1. Gluconeogenesis pathway where the following genes: glucose-6-phosphate, 
fructose-1, 6-bisphosphate, pyruvate carboxylase, and phosphoenolpyruvate carboxykinase, 
were selected for analysis due to their involvement with regulation of diabetes and obesity 
(Chung et al., 2015) 
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Another key enzyme in glucose production is glucose-6-phosphatase (G6PC). It catalyzes 
the terminal step of both gluconeogenic and glycogenolytic pathways, making it an important 
enzyme in homeostatic regulation of glucose (Lei et al., 1994; Danièle et al., 1997).  Deficiency 
of G6PC is a glycogen storage disease type 1a, which tends to develop during the first year of 
life and presents its self with sever hypoglycemia and hepatomegaly (Lei et al., 1994). G6PC 
also catalyzes phosphydrolase and glucose phosphotransferase activity in the liver (Arion et al., 
1971; van de Werve et al., 2000). It has also been noted that in the liver G6PC activity increases 
with fasting and diabetic states. For example, when insulin was administered to diabetic rats 
there was a decrease of G6PC to levels of non-diabetic rats (van de Werve et al., 2000). Since 
G6Pase is known for different responsibilities in many pathways it is generally considered a 
nonspecific enzyme with both catalytic and substrate/product transport properties (van de Werve 
et al., 2000). 
Gluconeogenesis is regulated by the activity of three regulatory and irreversible enzymes, 
phosphoenolpyruvate carboxykinase, glucose-6-phosphatase, and fructose-1,6-bipohsophatase 
(Lamont et al., 2005). Fructose-1,6-biphosphatase (FBPase) is upregulated in the liver by obesity 
and diabetes (Visinoni et al., 2012). Fructose-1,6-Bisphosphatase is a highly regulated, rate-
limiting enzyme the catalyzes the second to last step in gluconeogenesis (Erion et al., 2005). In 
the gluconeogenesis pathway FBPase catalyzes the dephosphorylation of fructose-1,6-
bisphosphate to fructose-6-phosphate (Kebede et al., 2008). The use of FBPase inhibitors as a 
possible therapy for diabetes has also started to emerge (van Poelje et al., 2006). A study 
conducted by van Peolje et al. (2006) used an FBPase inhibitor to determine if it would reduce 
glucose levels in the blood and combat the effects of type 2 diabetes. From this study researchers 
saw a 69% glycosuria reduction, along with after 1 week of  treatment, rats blood glucose levels 
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had been reduced by 33%, and by 44% by week 2 (van Peoje et al., 2006), leading researchers to 
see FBPase as a viable option for diabetes therapy.  
Pyruvate carboxylase (PC) is essential in many metabolic pathways including 
gluconeogenesis, lipogenesis, amino acid metabolism, and neurotransmitter synthesis (Agca and 
Donkin, 2007). Pyruvate carboxylase in mammals is a mitochondrial enzyme that is controlled 
by positive modulation where ligands enhances the binding of acetyl-CoA to PC (Jitrapakdee et 
al., 1998; Agca and Dokin, 2007). Pyruvate carboxylase is expressed in multiple tissues, with the 
highest being in liver and kidney but also has some presence in brain, heart and adrenal gland 
tissues (Jitrapakdee and Wallace, 1999). When PC is activated it catalyzes the HCO3- and 
MgATP-dependent carboxylation of pyruvate to form oxaloacetate, with this being the first 
committed step in gluconeogenesis (Jitrapakdee et al., 2008). This step provides oxaloacetate for 
conversion to phosphoenolpyruvate by phosphoenolpyruvate caboxylkinase PEPCK (Jirtapakdee 
et al., 2008). It has also been noted by many groups that PC activity increases during starvation 
or fasting, along with diabetes and obesity (Jitrapakdee and Wallace, 1999; Jitrapakdee et al., 
2008). In diabetic induced rat models, it was seen that they had a 2-fold increase of PC activity 
compared to non-diabetic control rats. Once these rats were given insulin PC activity was 
brought down to the same as the control rats (Jitrapakdee and Wallace, 1999), showing the 
importance of PC in gluconeogenesis. 
The phosphoenolpyruvate carboxykinase 1 (PCK1) gene codes for PEPCK-C, which is 
the first rate-limiting reaction of gluconeogenesis in the cytoplasm (She et al., 2000; Liu et al. 
2018). There are two isoforms: cytoplasmic (PCK1) and mitochondrial (PCK2), with the 
cytoplasmic isoform accounting for approximately 95% of the metabolic activity in the liver and 
kidneys (She et al., 2000; Liu et al. 2018). Phosphoenolpyruvate carboxykinase 1 catalyzes the 
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conversion of oxaloacetate (OAA) to phosphoenolpyruvate (PEP) (Méndez-Lucas et al., 2014). 
Elevated expression levels of PCK1 have also been seen in colon cancer and are linked to 
increases in glucose and glutamine utilization, supporting cancer cell proliferation (Liu et al., 
2018). It has also been observed that when PCK1 was deleted from mouse liver it ceased 
functionality of gluconeogenesis in that tissue (Yang et al., 2009).  
Insulin resistance is a common comorbidity of obesity and type 2 diabetes (Arner et al. 
1987). Insulin resistance is thought to be caused by an insulin receptor signal transduction 
disorder of target cells, either as a structural and functional change or a gene mutation (Chu et 
al., 2014). Insulin receptor and the downstream signaling produced is critical to maintaining 
metabolic homeostasis (Liauchonak et al., 2018). Insulin receptor (INSR) is a tetramer that is 
made up of two α and two β subunits expressed and is expressed in a variety of tissues (Chu et 
al., 2014). The α subunit specifically binds to insulin or insulin-like growth factor while the β 
subunit is a transmembrane protein with three domains: the juxtamembrane domain, tyrosine 
kinase domain, and C-terminal domain (Chu et al., 2014). When insulin binds to the α subunit it 
stimulates kinase activity of the β subunit activating INSR (Chu et al., 2014; Sasaki et al., 2015). 
Sasaki et al. (2015) reported that when cells are continuously exposed to insulin it causes a net 
loss of insulin receptors in the cell membrane. Overexpression of INSR in mice reduced the 
obese phenotype. It was also noted that the INSR-overexpressed mice had reduced 
hyperglycemia compared to the obese control group (Sasaki et al., 2015). This could potentially 
be a future genetic therapy available to humans that have insulin resistance.  
Sterol regulatory element binding protein 1c (SREBP-1c) is generally studied in the liver 
and adipose tissue and is controlled positively by insulin (Guillet-Deniau et al., 2002). Recent 
studies have shown that SREBP-1c has been detected in skeletal muscle of humans and rodents 
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(Guillet-Deniau et al., 2002). Bizeau et al. (2003) have reported that after feeding rats a high 
cornstarch diet there was an increase in SREBP-1c mRNA in skeletal muscle, appearing to 
respond to nutritional status such as liver and adipose tissue. The SREBP family is known to be 
involved with the transcription factors centered around cholesterol and fatty acid metabolism 
(Brown et al., 1997; Foretz et al., 1999). It has also been noted that SREBP-1c is enhanced by 
insulin, potentially causing increased transcription of SREBP-1c (Foretz et al., 1999). In a study 
conducted by Ducluzeau et al. (2001) individuals were separated into three groups: control, 
nondiabetic obese, and type 2 diabetic. Muscle and adipose tissue biopsies were performed to 
measure expression of SREBP-1c. Individuals in the type 2 diabetic groups tended to have lower 
expression of SREBP-1c than the control group in skeletal muscle (Ducluzeau et al., 2001). In 
adipose tissue there was a significant difference in SREBP-1c expression with a reduction in 
nondiabetic obese and type 2 diabetes individuals compared to the control group (Ducluzeau et 
al., 2001). These results tend to show that SREBP-1c does not play as significant of a role in 
skeletal muscle as in adipose tissue. 
Insulin-like growth factor 1 (IGF1) plays an important role in post-natal development, 
along with fetal development, particularly during late gestation (Chriett et al., 2016). Insulin-like 
growth factor 1 also acts postnatally by mediating the effects of growth hormones, acting as a 
stimulus for mitosis and differentiation factors, in tissues and cell lines (Liu et al., 1993). Insulin-
like growth factor 1 receptor (IGF1R) is present in multiple cell types and tissues, allowing for 
balanced growth when IGF1 concentrations increase (Clemmons, 2009). Concentrations are 
controlled locally within tissues as, when injury occurs, IGF-1 synthesis increases stimulating 
reparative cells to help restore tissue to its normal state (Clemmons, 2009). Once Synthesized, 
IGF1 is transported within interstitial fluids to cell surfaces where they bind to the receptor, 
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IGF1R (Clemmons, 2009).  IGF1R is a heterotetramer composed of two subunits that contain 
IGF binding sites and two subunits that contain intrinsic tyrosine kinase activity (Rosenthal et al., 
1991; Cheng et al., 2000; Clemmons, 2009). Once IGF1 binds, IGF1R undergoes a 
conformational change, activating intrinsic tyrosine kinase, creating a docking station for 
signaling proteins such as insulin receptor substrate 1 (IRS-1; Clemmons, 2009).  
Skeletal muscle is one the primary sites of insulin-stimulated glucose disposal. When 
metabolic abnormalities occur in insulin-sensitive tissues, obesity and diabetes can develop 
(Goodyear et al., 1995). In obese humans and rodents, impaired insulin-stimulated glucose 
transport in skeletal muscle is associated with the decrease of IRS-1 (Björnholm et al., 1997). 
Insulin receptor substrate 1 is a substrate of insulin receptor and acts as an interface between 
activated receptors and signaling proteins (Rondinone et al., 1997). When the subunits of INSR 
are activated, they stimulate receptor kinase activity inducing phosphorylation of IRS-1, which is 
needed for normal insulin stimulated glucose uptake (Goodyear et al., 1995).   
Insulin-like growth factor 2 (IGF2) is a single chain protein produced in the liver and 
released when growth hormone binds to growth hormone receptors (Oskbjerg et al., 2004). 
During early gestational development, IGF2 is heavily associated with the proliferation and 
differentiation of myoblast cells (Florini et al., 1991; Gerrard et al., 1997; Chriett et al., 2016). It 
has been reported by Petrik et al. (1999) that mRNA expression of IGF2 decreased in rat 
pancreases during the first two weeks of birth while IGF1expression increased to adult levels by 
weaning. Insulin-like growth factor 2 also interacts with secreted and cell surface associated 
binding proteins that can increase or inhibit IGF activity (Sarbassov et al., 1995). Insulin-like 
growth factor 2 has its own receptor much like IGF1 that is a single-chain polypeptide devoid of 
any tyrosine kinase activity (Liu et al., 1993). The IGF2 receptor binds exclusively to IGF2 and 
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does not recognize IGF1, while IGF1R recognizes both IGF1and IGF2, allowing it to binding 
(Liu et al., 1993). Since IGF2 can bind to IGF1R, when IGF2R is disrupted the actions of IGF2 
are not affected (Mottola and Czech, 1984). 
Obesity 
Leptin was first discovered studying ob/ob mice, which is a mutation in the ob gene 
resulting in a lack of leptin production (O’Rahilly et al., 2006). Leptin is involved in the 
regulation of appetite; when leptin absent individuals tend to overeat resulting in obesity 
(O’Rahilly et al., 2006). Leptin is a multifunctional peptide hormone that is involved in energy 
homeostasis, regulation of body weight, reproduction, angiogenesis and immune response, and 
acts on the leptin receptor (Melzner et al., 2002; Vauthier et al., 2012). When there is a loss of 
function in the leptin receptor the body becomes insensitive to leptin causing early-onset severe 
hyperphagic obesity (Saeed et al., 2014). There are six isoforms of leptin receptor (LEPR) due to 
alternative mRNA splicing. Of these only one, LEPRb, is responsible for leptin signaling (Saeed 
et al., 2014). When mice are deficient in LEPRb they show symptoms of morbid obesity, 
hyperphagia, and metabolic syndrome, similar to mice that have defects in all six isoforms, while 
when other isoforms have been deficient the effects have been less severe (Saeed et al., 2014). 
Hepatic lipase is coded by the lipase C (LIPC) gene and is involved in metabolism of 
plasma lipoproteins. It is synthesized by hepatocytes, secreted and eventually binds to the liver 
endothelium (Ameis et al., 1990). On the liver, hepatic lipase binds specifically to heparin sulfate 
proteoglycans located on the cell surface of hepatocytes and epithelial cells of the liver 
(Chatterjee and Sparks, 2011). Hepatic lipase hydrolyzes triglycerides and phospholipids in 
chylomicron remnants, LDL, and HDL, altering lipoprotein size and density (Sanan et al., 1997; 
Nong et al., 2003). When hepatic lipase is deficient there is a rise in triglycerides, HDL, and 
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VLDL in the plasma (Chatterjee and Sparks, 2011). Studies done in humans to understand the 
relationship between LIPC and obesity have examined relationships between hepatic lipase 
activity and effects on body mass index (BMI; Nie et al., 1998). Nie et al. (1998) determined that 
BMI and hepatic lipase activity were positively correlated. Multiple researchers have stated that 
there is a correlation between LIPC and body weights; unfortunately there is still not an 
understanding of how LIPC is causing the effects (Nie et al., 1998; Carr et al., 2004; Farahani et 
al., 2004). 
Fibroblast growth factor 21 (FGF21) is an endocrine hormone that signals through the 
cell-surface receptor complex (Markan et al., 2014). Fibro growth factor 21 is a metabolic 
regulator of glucose and lipid metabolism homeostasis and is expressed in multiple tissues, such 
as liver, white adipose tissue, brown adipose tissue, and pancreas (Coskun et al., 2008; Markan et 
al., 2014). Fibro growth factor 21 regulates the expression of the glucose transporter GLUT-1 
and promotes the uptake of glucose by 3T3 (fibroblast) cells and adipocytes in humans (Xu et al., 
2009; Lin et al., 2017). It has also been seen that once daily subcutaneous injection of FGF21 
reduced blood sugar levels and body weighs of mice with induced obesity by reducing the 
content of triglycerides in the liver and serum (Coskun et al., 2008).  Fibro growth factor 21 has 
potential as anti-obesity therapy, because when mice were injected with FGF21 there was a 
decrease in total adiposity and decrease in total body weight (Coskun et al., 2008). This 
reduction is thought to occur because of an increase in energy expenditure and fat utilization, 
leading researchers to believe that FGF21 could have long term potential for therapeutics in 
obesity (Coskun et al., 2008). 
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Hypothesis and Objectives  
Our hypothesis for this study is that feeding gestating sows ground beef, which is rich in 
protein and fat, will benefit fetal development and offspring growth and metabolism, in aspects 
of obesity and diabetes, compared to the typical high-sugar diet of American pregnant women.  
Our objectives include discovering different gene expression between protein and sugar 
supplements. Along with determining if these dietary treatments have an effect on offspring’s 
body weight, back fat, longissimus dorsi muscle area, and insulin levels later in life.  
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CHAPTER 2: THE ROLE OF SUPPLEMENTAL BEEF VS SUGAR DURING 
PREGNACY ON FETAL DEVELOPMENTAL PROGRAMMING IN SWINE 
Abstract 
The purpose of this study was to determine the influence of substituting supplemental 
beef in place of a sugar snack on fetal developmental programming. A total of 21 multiparous 
sows (Landrace x Yorkshire; initial BW 221.58 ± 33.26 kg) were bred via artificial insemination 
to a common sire and fed a complete gestation diet (corn-soybean meal, CSM) at one percent of 
gestational BW through 110 ± 0.58 d of gestation. Sows were randomly assigned to 1 of 4 
isocaloric supplement treatments: control supplement, 126 g CSM (CON, n = 5); sugar 
supplement, 85 g crystalized sugar (SUGAR, n = 5); cooked beef supplement, 110 g (BEEF, n = 
6); or sugar + beef supplement, 55 g cooked beef and 43 g crystalized sugar (B+S, n = 5). 
Supplements were fed three times daily from d 40 to 110 of gestation. Sows were euthanized on 
d 111± 0.58 of gestation. The longissimus muscle and liver were collected from two male and 
two female fetuses of median weight from each litter and preserved in RNAlater. Gene 
expression was measured via qPCR with HPRT1 as the reference gene for both muscle and liver 
samples. The following genes were selected due to associations with metabolic function and 
analyzed in the muscle: GYS-1, IGF1R, IRS-1, LEPR, INSR, SREBP-1C, IGF2, and IGF2R; 
while the following were analyzed in the liver: FGF21, FBPase, G6PC, IGF2, IGF2R, LIPC, 
PC, and PCK1. Data were analyzed using the GLM procedure of SAS. No significant effects of 
treatment were observed for any of the following genes analyzed: GYS-1 (P = 0.70); IGF1R (P = 
0.32); IGF2R (P = 0.12); INSR (P = 0.47); IRS-1 (P = 0.45); LEPR (P = 0.67); SREBP-1C (P = 
0.26); FGF21 (P = 0.43); G6PC (P = 0.40); IGF2 (P = 0.26); LIPC (P = 0.21); PC (P = 0.27); 
PCK1 (P = 0.59). In muscle tissue IGF2 expression showed significant effects (P= 0.049) based 
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on treatment, with B+S (1.12 ± 0.47) and SUGAR (1.08 ± 0.47) being significantly down 
regulated compared to CON (2.67 ± 0.46) treatment. In the liver, FBPase (P = 0.032) based on 
treatment, with B+S (2.68 ± 0.30) treatment having greater expression compared to CON (1.43 ± 
0.28) and SUGAR (1.88 ± 0.28) treatments. In the liver, IGF2R (P = 0.026) showed significant 
effects based on treatment, with B+S (0.12 ± 0.33) and SUGAR (0.20 ± 0.31) treatments being 
significantly down regulated compared to the BEEF (1.27 ± 0.30) treatment.  There was no effect 
of sex or the sex by treatment interaction (P > 0.05) for any of the genes analyzed. We conclude 
that maternal beef or sugar supplementation during gestation altered expression of specific genes 
in both the fetal liver and muscle in this swine model.  
Introduction 
Diabetes and obesity are two of the most rapidly growing diseases in the world, with 
diabetes rising from 4.7 % in 1980 to 8.7 % in 2014, and with 13 % of the world being 
considered obese (WHO, 2017; WHO, 2018). Both diseases can be prevented or delayed when 
an individual manages their diet, physical activity, and medication (WHO, 2017; WHO, 2018). 
Due to the increase in these diseases, women who are pregnant are possibly passing these 
diseases to their offspring via developmental programming (Li et al., 2011).  
Previous research focused on what would happen to offspring of a mother who was under 
nourished, but in recent years, with the increase of obesity and diabetes, researchers have 
switched their focus to maternal over nutrition (Bayol et al., 2005). To fully understand what is 
happening to the offspring of these women, swine are being used as models for human 
pregnancy due to similar anatomy and disease progression. These similarities allow researchers 
to apply new knowledge to human medicine (Aigner et al., 2010; Gutierrez et al., 2015; 
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Koopmans et al., 2015). For this study, pigs were the ideal model due to their large litter sizes 
and physiological similarities to humans (Larsen et al., 2002; Litten-Brown et al., 2010). 
Genes of interest to study in the offspring were selected based upon their association with 
basic metabolic functions related to obesity and diabetes. The genes selected were involved in 
the following pathways as they are rate-limiting in the pathways steps: insulin-like growth factor 
pathway, insulin signaling, gluconeogenesis, and adipocyte metabolism (Jones and Clemmons, 
1995; Attie and Scherer, 2009; Chung et al., 2015). We hypothesize that feeding a diet rich in 
protein and fat, such as ground beef, will benefit the offspring’s metabolic state compared to the 
typical high sugar diet of American women during pregnancy.   
Methods and Materials  
All animal care protocols described (protocol number A17010) were approved by the 
North Dakota State University Animal Care and Use Committee.  
Experimental Design and Treatments 
A total of 21 multiparous pregnant sows (Landrace x Yorkshire) with a starting body 
weight of 222 ± 35 kilograms were used in a biomedical study to investigate the effects of 
supplementing ground beef and sugar during mid to late gestation on fetal development. Sows 
were group housed and bred using artificial insemination. Pregnancy was confirmed via 
ultrasound (Aloka SSD-500V, Corometrics Medical Systems, Inc., Wallingford, CT) on d 29 
after breeding. Sows that were confirmed pregnant were then moved to farrowing crates for 
housing (19.4°C temperature, and exposed to light from 0700 to 1800 h daily). Sows were fed a 
complete gestation diet (corn-soybean meal, CSM, Table 2.1) which was provided at 1% of d 30 
gestation BW at 0700 h from d 40 to d 110 of gestation. Sows were then randomly assigned to 1 
of 4 isocaloric supplement treatments (Table 2.2) consisting of 126 g CSM (CON, n = 5), 110 g 
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cooked ground beef (BEEF, n = 6, Food Service Direct, Hampton, VA), 54.8 g cooked ground 
beef and 42.7g sugar (B+S, n = 5), or 85.5 g of granulated table sugar (SUGAR, n = 5). These 
supplements were fed in full at 1100, 1500, and 1800 h from d 40 to 110 of gestation. All sows 
were provided ad libitum access to water. Sows were euthanized on d 111 of gestation. 
Longissimus muscle and liver samples were collected from two male and two female fetuses that 
were of medium weight from each individual litter (n = 84). Longissimus muscle and liver 
samples were then preserved in RNAlater (Thermo Fisher Scientific Inc., Waltham, MA) and 
stored at -20°C. 
Table 2.1. Diet and nutrient composition of material gestation basal diet 
 Gestation 
Ingredient, % of DM  
Corn 70.77 
Soybean Meal 9.85 
Soy Hulls 14.99 
MonoCalcium 1.47 
Limestone 1.06 
Fat, Choice White Grease  0.75 
Salt 0.45 
Choline 60 (Dry)  0.11 
EnMax Sow Premix 101 0.50 
L-Lysine -- 
L-threonine  -- 
Dl-methionine  -- 
Nutrient Analysis 2  
Dry Matter (DM), % 89.21 
Carbohydrates, % of DM 57.21 
Ash, % of DM 5.89 
Crude Protein, % of DM 12.53 
Total Dietary Fiber, % of DM 20.87 
Ether Extract, % of DM 3.49 
Calcium, % of DM 0.84 
Phosphorus, % of DM 0.65 
1 Contains 18.18% crude protein (CP), 15.10% 
lysine (Lys), 1.60% crude fiber (CF), minimum 
3.5% calcium (Ca), maximum 4.50% calcium 
(Ca), 59.99 parts per million (ppm) selenium  
(Se), 18,814 ppm zinc (Zn), 63,750 phytase 
activity (FTU/Ib) phytase. 
2 Average of all 2 repetitions 
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Table 2.2. Feed analysis of sow supplemental diets by dietary treatment groups 
 CON 
Supplement2 
BEEF 
Supplement3 
SUGAR 
Supplement4 
B+S 
Supplement5  
Ingredients      
Dry Matter (DM) 
% 
89.33 
99.15 99.6 -- 
Carbohydrates, % 
of DM1 
58.73 
0.11 100.0 50.11 
Ash, % of DM 5.70 3.35 0.00 1.67 
Crude Protein, % 
of DM 
13.46 
48.67 0.00 24.33 
Total Dietary 
Fiber, % of DM 
18.42 
0.00 0.00 0.00 
Ether Extract, % 
of DM 
3.69 
47.87 0.00 23.93 
Calcium, % of 
DM 
0.71 
0.02 0.00 0.01 
Phosphorus, % of 
DM 
0.74 
0.42 0.00 0.21 
1 DM= Dry Matter. 
2 CON = control. 
3 BEEF = cooked ground beef supplement; 110 g, n = 6. 
4 SUGAR = granulated sugar supplement; 85.5 g, n = 5.  
5 B+S = half cooked ground beef (54.8 g) and half granulated sugar (42.7 g); n = 5. 
 
Gene Expression 
Prior to RNA extraction, 50 mg of muscle and 30 mg of liver tissue was lysed in 1 ml 
QIAzol Lysis reagent (Qiagen, Hilden, Germany), and extracted with 200 µl chloroform (VWR, 
West Chester, PA). The aqueous phase was then combined with 500 µl isopropanol (Merk, 
Darmstadt, Germany). RNA extraction of tissues was based on the procedure presented in the 
Qiagen RNeasy Lipid Tissue Mini Kit Handbook (Qiagen). RNA quantity was determined using 
the Qubit 3.0 Fluorometer (Thermo Fisher Scientific Inc.). RNA was reverse transcribed to 
cDNA using the Applied Biosystems High-Capacity cDNA Reverse Transcription Kit (Thermo 
Fisher Scientific Inc.). A 20 µl qPCR cocktail was made using 10 µl of iTaq Universal SYBR 
Green Supermix (Bio-Rad Laboratories Inc., Hercules, California), 1 µl each of 10 µM forward 
and reverse primers (Integrated DNA Technologies, Skokie, IL, Table 2.3), 6 µl RNAase-free 
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water, and 2 µl (1ng/µl) cDNA. All primers were designed using Primer-Blast (National Center 
for Biotechnology Information, Bethseda, MD). Expression of genes of interest was quantified in 
triplicate using Applied Biosystems 7500 Fast qPCR machine (Thermo Fisher Scientific Inc.). 
Relative gene expression was calculated using the 2-ΔΔCt method (LiVak and Schmittgen, 2001) 
with hypoxanthine phosphoribosyltransferase 1 (HPRT1) as the reference gene, which was 
chosen as a reference gene due to its low M value (Biogazelle qbase+ software, BioGazelle, 
Zwijnaarde, Belgium), indicating consistent expression across treatment groups.  
Statistical Analysis 
This experiment was a completely randomized 2 x 4 factorial treatment design comparing 
fetal sex (male vs. female) with dietary treatment (CON vs. BEEF vs. B+S vs. SUGAR). Data 
were analyzed using the GLM procedure in SAS (v. 9.4; SAS Inst., Cary NC). Fixed effects 
included fetal sex, treatment, and the interaction between the two. Means were separated using 
the least significant difference method, and P-values < 0.05 were considered significant.  
 
 
  
4
9
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Table 2.3. Primer sequences used for real-time quantitative PCR analysis 
Gene1 Accession No. Forward Reverse 
GYS-1 NM_001195508.1 CAGGACTGGAAGATTGGGAGG AGTAGTTGTCGCCCCATTCA 
INSR XM_005654749.2 GCCTTTCAAACGAGCAGGTG GCATCTTGGGGTTGAACTGC 
IRS-1 NM_001244489.1 AGAGGACCGTCAGTAGCTCA GAAGGTGTGAGGTCCTGGTT 
IGF1R NM_214172.1 GATTCAGGCCACCTCTCTCTCC CCCTCCTACTATCAACAGAACGGC 
IGF2 NM_213883.2 ACACCCTCCAGTTTGTCTGC TGGAATCTGCCTTTTTCACC 
IGF2R NM_001244473.1 CAGGAACTGCTTTCTGAGCA GGGGTATCTGGGGAAGTTGT 
LEPR NM_001024587.1 TCTGCTCCCCCAGAAAGGTA CACAGGCACATGGCATTCAC 
SREBP-1C NM_214157.1 AATAAATCCGCCGTCTTGCG CTGCTTGAGCTTCTGGTTGC 
LIPC NM_001143714.1 GCCTGGGATTAGAGCTACTGG CTGACAGCCCTGATCGGTTT 
PCK1 NM_001123158.1 CAAGGAGAGAAAACGTAGGCGA TTTGAGAGCTGAGGAGGCAT 
G6PC NM_001113445.1 TTGCTGGAGTCTTGTCAGGC TTCTTGAGGCTGGCGTTGTA 
PC NM_214349.1 TACGTCGCCCACAACTTCAG GAAGCGCATCGCAACATCAA 
FGF21 NM_001163410.1 CACGTCCCATTCCTGACTCC AGTTTCCTGGGCATCATCCG 
FBPase NM_213979.1 GAGTTCGACCCTGCCATCAC TCCCTCCATAGACCAGCGTG 
HPRT1 XM_021079504.1 GGGAGGCCATCACATCGTAG CGCCCGTTGACTGGTCATTA 
1 GYS-1 – Glycogen synthase 1; INSR – Insulin receptor; IRS-1 – Insulin receptor substrate 1; IGF1R – Insulin like 
growth factor 1 receptor; IGF2 – Insulin like growth factor 2; IGF2R – Insulin like growth factor 2 receptor; LEPR – 
Leptin receptor; SREBP-1c – Sterol regulatory element binding protein 1c; LIPC – Hepatic lipase; PCK1 – 
Phosphoenolpyruvate carboxykinase 1; G6PC – Glucose 6 phosphatase; PC – Pyruvate carboxylase; FGF21 – 
Fibroblast growth factor 21; FBPase – Frucose 1,6 bisphosphatase; HPRT1 – Hypoxanthine phosphoribosyltransferase 
1. 
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Results and Discussion 
Gluconeogenesis is an important metabolic pathway that helps generate glucose via the 
liver (Chung et al., 2015). When glucose levels are low due to fasting, glucose production 
decreases due to a decrease in glycogenolysis and glycogen stores are depleted through the 
gluconeogenesis steps in order to aid glucose homeostasis (Chung et al., 2015; Miyamoto and 
Amrein, 2017). For this study we measured the expression of multiple genes within the 
gluconeogenesis pathway: glucose-6-phosphatase (G6PC), fructose 1, 6-bisphosphatase 
(FBPase), glycogen synthase 1(GYS-1), pyruvate carboxylase (PC), and phosphoenolpyruvate 
carboxykinase 1 (PCK1). There was no effect of treatment (Table 2.4), sex, or sex by treatment 
interaction (Table 2.5) on hepatic gene expression of G6PC (P = 0.40), GYS-1 (P = 0.70), PC (P 
= 0.27), or PCK1 (P = 0.59). Interestingly, there was a difference between treatments on the 
expression of FBPase (P = 0.03). Expression of FBPase was upregulated in the B+S treatment 
compared to the CON. It is unclear why increased expression was observed in the B+S treatment 
but not in the individual BEEF or SUGAR treatments. It is possible that there is a synergistic 
interaction between beef and sugar supplementation. Interest has been generated in FBPase as a 
target for treatment of type 2 diabetes. For example, treatment for one week with an FBPase 
inhibitor reduced blood glucose concentration by 33% in people with type 2 diabetes (Lamont et 
al., 2006; Van Poelie et al., 2006).  
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Table 2.4. The effect of maternal diet on fetal muscle and liver gene expression. 
Gene1 CON BEEF SUGAR B+S SED2 P-value 
Muscle       
GYS-1 2.39 4.40 2.24 2.33 1.69 0.70 
IGF1R 4.19 5.61 22.80 2.28 9.38 0.32 
IGF2 2.67a 1.99ab 1.08b 1.11b 0.46 0.04 
IGF2R 2.10 3.93 3.74 12.94 3.48 0.12 
INSR 0.46 1.14 0.54 0.47 0.39 0.47 
IRS-1 0.23 0.60 0.25 0.35 0.19 0.45 
LEPR 0.38 0.38 0.35 0.21 0.11 0.67 
SREBP-1c 1.68 1.02 1.00 3.67 1.10 0.26 
Liver       
FGF21 1.63 1.89 0.95 0.45 0.70 0.43 
FBPase 1.42a 2.01ab 1.88a 2.67b 0.30 0.03 
G6PC 1.72 1.13 0.81 0.49 0.56 0.40 
IGF2 0.57 0.42 0.44 0.08 0.18 0.26 
IGF2R 0.96ab 1.26a 0.20b 0.11b 0.32 0.02 
LIPC 6.88 5.87 0.74 1.25 2.62 0.21 
PC 1.20 1.27 0.60 1.83 0.44 0.27 
PCK1 0.54 0.66 0.25 0.26 0.26 0.59 
1 GYS-1 – Glycogen synthase 1; INSR – Insulin receptor; IRS-1 – 
Insulin receptor substrate 1; IGF1R – Insulin like growth factor 1 
receptor; IGF2 – Insulin like growth factor 2; IGF2R – Insulin like 
growth factor 2 receptor; LEPR – Leptin receptor; SREBP-1c – Sterol 
regulatory element binding protein 1c; LIPC – Hepatic lipase; PCK1 – 
Phosphoenolpyruvate carboxykinase 1; G6PC – Glucose 6 phosphatase; 
PC – Pyruvate carboxylase; FGF21 – Fibroblast growth factor 21; 
FBPase – Frucose 1,6 bisphosphatase; HPRT1 – Hypoxanthine 
phosphoribosyltransferase 1. 
2 SED = standard error of the difference within sex. 
3 a,bMeans with differing superscripts within a row differ (P < 0.05). 
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Table 2.5. The effect of sex and sex by treatment interaction on fetal muscle and liver gene 
expression 
Gene1 Male Female P-value SED2 
Sex*Treatment  
(P-value) 
Muscle      
GYS-1 2.43 3.25 0.60 1.14 0.41 
IGF1R 3.55 13.89 0.23 6.22 0.34 
IGF2 2.03 1.39 0.16 0.32 0.16 
IGF2R 4.24 7.12 0.39 2.40 0.31 
INSR 0.49 0.81 0.39 0.26 0.45 
IRS-1 0.28 0.43 0.43 0.13 0.46 
LEPR 0.31 0.35 0.70 0.07 0.59 
SREBP-1c 2.14 1.54 0.56 0.74 0.75 
Liver      
FGF21 1.37 1.08 0.66 0.48 0.40 
FBPase 1.95 2.04 0.75 0.20 0.75 
G6PC 1.13 0.95 0.71 0.36 0.47 
IGF2 0.51 0.25 0.13 0.12 0.84 
IGF2R 0.68 0.59 0.77 0.22 0.64 
LIPC 3.69 3.67 0.99 1.79 0.11 
PC 1.00 1.45 0.29 0.30 0.11 
PCK1 0.46 0.60 0.57 0.18 0.22 
1 GYS-1 – Glycogen synthase 1; INSR – Insulin receptor; IRS-1 – 
Insulin receptor substrate 1; IGF1R – Insulin like growth factor 1 
receptor; IGF2 – Insulin like growth factor 2; IGF2R – Insulin like 
growth factor 2 receptor; LEPR – Leptin receptor; SREBP-1c – 
Sterol regulatory element binding protein 1c; LIPC – Hepatic 
lipase; PCK1 – Phosphoenolpyruvate carboxykinase 1; G6PC – 
Glucose 6 phosphatase; PC – Pyruvate carboxylase; FGF21 – 
Fibroblast growth factor 21; FBPase – Frucose 1,6 bisphosphatase; 
HPRT1 – Hypoxanthine phosphoribosyltransferase 1. 
2 SED = standard error of the difference within sex. 
 
No effect of maternal diet was found on the expression of IGF1R (P = 0.32, Table 2.4). 
Dietary treatment had a significant effect on fetal expression of IGF2 in the muscle (P = 0.04) 
and IGF2R in the liver (P = 0.02). When looking into the main effect of sex and the interaction 
between sex and treatment there was no significant difference between treatments for IGF1R, 
IGF2, and IGF2R (P ≥0.13 and P ≥ 0.16, respectively). Looking specifically at the different 
supplements affecting IGF2, Table 2.4 depicts the differences in IGF2 between the supplements 
where SUGAR and B+S are down regulated compared to CON. Looking at IGF2R, the SUGAR 
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and B+S treatments were downregulated compared to the CON supplement. Insulin has an effect 
on the insulin like growth factor (IGF) pathway by acting as a growth promotant working 
alongside insulin receptor (INSR) and insulin receptor substrate 1 (IRS-1, Wilcox, 2005). When 
growth hormone (GH) is released by the anterior pituitary gland, into the blood stream it 
stimulates the liver to produce insulin like growth factor 1 (IGF1) and insulin like growth factor 
2 (IGF2) (Yakar, et al. 2002). IGF1 and IGF2 each have their own receptors, insulin like growth 
factor 1 receptor (IGF1R) and insulin like growth factor 2 receptor (IGF2R), respectively. IGF1 
is able to bind to IGF1R and INSR/IGF1R hybrid with high affinity, and to INSR with low 
affinity. IGF2 is able to bind to IGF2R and INSR/IGF1R with high affinity, while IGF2 binds to 
IGF1R and INSR individually with a low affinity (reviewed by Annunziata et al., 2011). The 
main function of these receptors is to mediate the actions of IGF1 and IGF2, along with insuring 
downstream steps do not get over saturated with insulin (Jones and Clemmons, 1995). IGF1R, 
IGF2, and IGF2R were selected due to their involvement with insulin and their abilities to cause 
insulin resistance when damage or disease is present (Wilcox, 2005). Insulin resistance is 
thought to be mainly at the cellular level caused by receptor defects, but has also been seen with 
hormone imbalances (Wilcox, 2005).  
One possible explanation for the observed downregulation for both IGF2 and IGF2R 
could be the relationship these genes have with growth mechanisms in the fetus (St-Pierre et al., 
2012). It has been seen that IGF2 and IGF2R are heavily related to cell differential and cell 
proliferation, while IGF1 is related to fetal size (Agrogiannis et al., 2014). An explanation as to 
why IGF2 and IGF2R were down regulated could be due to the time of tissue collection. In 
sheep expression of IGF2 decreases with gestational age (Delhanty and Han, 1992). In our study 
tissue was collected at d 110 of gestation, therefore the fetuses were nearly full term. As we have 
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previously reported (Nelson et al., 2018), there was no effect of maternal dietary treatment on 
fetal weight. It is possible that the down regulation of IGF2 and IGF2R expression in fetuses 
from the SUGAR and B+S treatments may be a compensatory mechanism to prevent excessive 
fetal growth from increased maternal blood sugar concentration.  
Insulin acts to regulate blood glucose levels, lipid metabolism, cell division, and growth 
(Wilcox, 2005). Insulin resistance is the result of the body not being able to properly use insulin 
(Wilcox, 2005). Insulin receptor signaling is activated by the binding of insulin, resulting in 
changes to cell division and metabolism (Lee and Pilch, 1994). Additionally, insulin is able to 
bind to IRS-1 which acts a “pitstop” to organize and meditate other signaling complexes in the 
body (Boucher et al., 2014). As a result of the mediating duties of IRS-1 it positively regulates 
sterol regulatory element-binding protein 1-c (SREBP-1c) expression (Kohjima et al, 2008). The 
main responsibility of SREBP-1c is as a transcription factor that regulates the expression of 
genes involved in lipid synthesis (Kohjima et al, 2008). These three genes, INRS, IRS-1, and 
SREBP-1c, were selected for this study due to their involvement with insulin and their effects on 
diabetes and obesity. There was no effect of treatment on the expression of INSR (P = 0.47), IRS-
1 (P = 0.45), or SREBP-1c (P = 0.26, Table 2.4). There was also no significant difference (Table 
2.5) for sex or the interaction between sex and treatment for each of the genes investigated (P > 
0.39 and P > 0.45, respectively). 
Type 2 diabetes and obesity are generally discussed together due to individuals usually 
having both diseases. When a person is considered obese, nonesterified fatty acids are secreted 
from adipose tissue in excess they cause insulin resistance to increase (AI-Goblan et al., 2014). 
When an antilipolytic agent is used, nonesterified fatty acids levels decrease, improving insulin 
uptake. Even though these diseases are heavily related in aspects of diet and lifestyle, obesity has 
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slightly different genes that affect an individual (AI-Goblan et al., 2014). Leptin and its receptor 
(LEPR) is heavily associated with obesity as it regulates appetite and when absent or at low 
levels individuals tend to over eat (O’Rahilly et al., 2006). A second gene involved in obesity is 
Hepatic lipase (LIPC), which is involved in lipoprotein metabolism (Ameis et al., 1990). 
Research has suggested that when LIPC activity increases a person tends to have a larger BMI 
(Nie et al., 1998). A third gene, Fibroblast growth factor 21 (FGF21), is being used as a potential 
anti-obesity therapy, since its main function is as a metabolic regulator of glucose and lipid 
metabolism (Coskun et al., 2008; Markan et al., 2014). These three genes where selected due to 
their involvement in obesity related pathways. From these selected genes, there was no 
significant difference based on treatment for LEPR (P = 0.67), LIPC (P = 0.21), and FGF21 (P = 
0.43). There was also no significant difference between sex, and our sex and treatment 
interaction (P > 0.66 and P > 0.11, respectively)  
One reason differences may not have been observed differences in genetic expression 
was due to the time supplemental diets were introduced, missing the first 30 days of pregnancy, 
where most exponential growth and development occur (Robinson and McDonald, 1979). 
Additionally, the amount of sugar supplemented may have been sufficient to induce any diabetic 
or obesity related epigenetic changes in the fetuses. The average American women has a body 
weight of 76.4 kg (Fryar et al., 2016) and consumes approximately 111 g of sugar daily 
(NHANES, 2017). This equates to an average daily intake of approximately 1.45 g of sugar per 
kg body weight. In comparison, the SUGAR treatment provided 1.15 g of sugar per kg of sow 
body weight. The SUGAR treatment was formulated to be isocaloric to three cooked ground beef 
patties (i.e. the BEEF treatment), however this may have been too conservative to truly replicate 
the North American diet.  
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Conclusion 
From this study it can be determined that the treatments in place did not have an overall 
significant effect on fetal metabolism based on the gene expression results. With our original 
hypothesis stating that beef could have beneficial results when replacing sugar in the diet of 
pregnant sows, we expected to see that the B+S supplement would have fallen in between the 
BEEF and SUGAR supplements; however, this was not the case in some of the genes analyzed 
during this study. To fully understand the effects of a beef and sugar in the diet of pregnant sows, 
further research would need to be conducted.  
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CHAPTER 3: THE ROLE OF SUPPLEMENTAL BEEF VS SUGAR DURING 
PREGNANCY ON OFFSPRING GROWTH AND DEVELOPMENT IN SWINE 
Abstract 
In this study swine were used to investigate the influence of substituting supplemental 
beef in place of sugar on offspring growth and development. A total of 35 multiparous sows 
were bred to two full-sibling boars via artificial insemination. Sows were randomly assigned to 
one of four isocaloric supplementation treatments: 126 g CSM (CON, n = 5), 110 g cooked 
ground beef (BEEF, n = 6), 85.5 g of granulated table sugar (SUGAR, n = 5), or 54.8 g cooked 
ground beef plus 42.7 g sugar (B+S, n = 5). Supplements were fed daily in full at 1100, 1500, 
and 1800 h from d 40 of gestation until weaning. On d 0 and d 2 of age piglet blood glucose 
concentrations were measured. Body weight was recorded on d 0, 6, 12, and 18. On d 18 piglets 
were weaned and the median weight male and female from each liter was selected for additional 
observations. Weight was measured on d 28 and every 14 d there after until d 160. Subcutaneous 
fat and longissimus dorsi muscle area were measured via ultrasonography on d 84, 98, 112, 126, 
and 140. An intravenous glucose tolerance test was performed on d 144 ± 8. Plasma insulin 
concentration was measured via radioimmunoassay. Blood glucose concentrations on d 0 and d 
2, body weight, subcutaneous fat, and longissimus dorsi muscle area were analyzed using the 
mixed procedure of SAS with sex, repetition, day, and treatment as fixed effects. Significance 
was set at P < 0.05.  Blood glucose concentrations on d 0 and d 2 had a significant treatment (P = 
0.005), day (P = 0.001), and treatment by day (P = 0.04) effect, with SUGAR piglets having 
greater d 0 blood glucose concentration than the other treatments. Body weight had a significant 
sex (P = 0.003) and sex by day (P <0.0001) effect, with a tendency for treatment by day (P = 
0.09) and no effect of treatment, sex, or treatment by sex interaction. Subcutaneous fat had a 
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significant sex by day effect (P = 0.01), while treatment, sex, and treatment by day were not 
significant. Longissimus dorsi muscle area was significantly affected by treatment by sex 
interaction (P = 0.001) with female SUGAR piglets having greater LDMA than females from 
other treatment and male BEEF greater than BEEF and B+S males. Insulin total area under the 
curve, net area under the curve, and positive area under the curve were not affected by treatment 
or sex. Insulin was significant over time (P < 0.0001), treatment by sex (P = 0.0002), sex by 
treatment (P = 0.002), and sex by time showing tendencies (P = 0.07), sex, treatment, and 
treatment by time were not significant. In conclusion, isocaloric substitution of sugar 
supplementation with beef during gestation had differential effects on developmental 
programming depending on offspring sex. 
Introduction 
In 2018, the World Health Organization (WHO, 2018) reported approximately 39% and 
13% of the world population is overweight and obese, respectively. The increase of these 
diseases is thought to occur due, in part, to the mother’s diet during pregnancy (Li et al., 2011). 
Individual’s growth and development, such as body weight, fat disposition, and hormone levels, 
throughout life are affected by what their mother consumed during pregnancy (Roseboom et al., 
2006; Vaiseman, 2017). Different lifestyles, such as under or over nutrition during pregnancy, 
can cause an individual to experience weight problems later in life. Specifically, a maternal diet 
that is high in either sugar or fat causes the offspring to accumulate fat storages in their bodies 
(Li et al., 2011). The idea that over nutrition during pregnancy causes diabetes, obesity, and other 
metabolic diseases has been shown multiple times in rat and sheep models (Li et al., 2011). 
Obesity and other related metabolic disorders are thought to be caused by high intake of 
processed or ‘junk foods’ that contain a high amount of calories, fats, or sugars (Breier et al., 
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2001; Bayol et al., 2005). Two studies conducted by Bayol et al., (2005; 2007) fed a normal rat 
chow or a cafeteria diet, which contained palatable foods high in fats and sugars, to pregnant rats 
to determine if fat deposits increased in the offspring of the cafeteria diet. From these studies, it 
was determined that mothers on the cafeteria diet had increased birth weights compared to the 
control diets, and treatment offspring exhibited muscle atrophy, intramuscular fat accumulation, 
and overall increase in adipose tissue weight (Bayol et al., 2005; Bayol et al., 2007). 
Obesity and diabetes are heavily connected, with both diseases leading to insulin 
resistance and increased adiposity (Kaur, 2014). A study conducted by Nivoit et al. (2009) 
investigated how maternal obesity affected offspring in a rat model. Rats were either fed a 
standard chow diet or a highly palatable diet enriched with lard, sugar, and supplemented with 
sweetened condensed milk, prior to breeding, during gestation, and through lactation (Nivoit et 
al., 2009). It was reported that offspring from the treatment diet were heavier in weight and in 
adiposity (Nivoit et al., 2009). It was also seen that at 11 months of age, males from obese 
mothers have significantly increased fasting plasma insulin levels compared to control, 
suggesting insulin resistance (Nivoit et al., 2009).  
For the current study, swine were used as a model for human pregnancy to investigate 
how maternal diet affected offspring growth from d 0 to approximately 5.5 months of age.  
Swine are being used as models for human pregnancy due to similar anatomy and disease 
progression (Lunney, 2007). The objective of this study was to determine if a maternal diet rich 
in protein and fat, such as ground beef, would benefit offspring growth and metabolism 
compared to the typical high sugar diet of American women during pregnancy. We hypothesized 
that piglets from the BEEF treatment would have lower subcutaneous fat and greater insulin 
response to a glucose challenge than SUGAR piglets, with B+S being intermediate. 
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Methods and Materials  
All animal procedures performed in this study were approved by the North Dakota State 
University (NDSU) Institute for Animal Care and Use Committee (Protocol #A17010). 
Procedures for this study were conducted at the NDSU Swine Research Unit and the NDSU 
Animal Nutrition and Physiology Center. 
Experimental Design and Treatments  
Purebred Yorkshire and crossbred Chester White x Yorkshire sows (n = 35) of at least 14 
months of age were bred to two full-sibling Hampshire x Duroc boars. At approximately d 30 
post-insemination, sows were confirmed pregnant via ultrasonography (Veterinary Ultrasound 
Scanner, Model 8300 Class I Type B) and moved into individual gestation stalls (84” L x 22” W 
x 48.75” H). Sows were provided with music (when lights were on), and chains were used as a 
means of environmental enrichment. 
Sows were fed a standard gestation diet (Table 3.1) formulated to meet the nutritional 
guidelines provided by the National Research Council (NRC, 1998). Target intake was 2.04 kg 
of standard diet per day, however adjustments were made according to body condition score. 
Sows were fed the standard gestation diet (corn-soybean meal, CSM, Table 3.1) at 0700 h from 
d 40 to d 110. Sows were then randomly assigned to 1 of 4 isocaloric supplements (Table 3.2) 
consisting of 126 g CSM (CON, n = 5), 110 g cooked ground beef (BEEF, n = 6, Food Service 
Direct, Hampton, VA), 85.5 g of granulated table sugar (SUGAR, n = 5), or 54.8 g cooked 
ground beef plus 42.7 g sugar (B+S, n = 5). These supplements were fed in full at 1100, 1500, 
and 1800 h from d 40 through farrowing and weaning. All sows were provided ad libitum access 
to water.  
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At d 110 of gestation, sows were moved from the gestational research room to the 
farrowing room. At this time, sows were switched to a lactation diet (Table 3.1) and fed 
approximately 2.04 kg at 0700 and 1500 daily. Supplements were provided as described above. 
Once farrowed, the lactation diet was provided at appetite for each sow.  
Table 3.1. Diet and nutrient composition of material gestation and lactation basal diets 
 Gestation Lactation 
Ingredient, % of DM   
Corn 70.77 71.55 
Soybean Meal 9.85 23.35 
Soy Hulls 14.99 -- 
MonoCalcium 1.47 1.42 
Limestone 1.06 1.09 
Fat, Choice White Grease 0.75 1.25 
Salt 0.45 0.45 
Choline 60 (Dry)  0.11 0.12 
EnMax Sow Premix 101 0.50 0.50 
L-Lysine -- .125 
L-threonine -- 0.06 
Dl-methionine -- .035 
Nutrient Analysis 2   
Dry Matter (DM), % 89.21 86.77 
Carbohydrates, % of DM 57.21 -- 
Ash, % of DM 5.89 5.80 
Crude Protein, % of DM 12.53 19.33 
Total Dietary Fiber, % of DM 20.87 -- 
Ether Extract, % of DM 3.49 2.77 
Calcium, % of DM 0.84 0.77 
Phosphorus, % of DM 0.65 0.80 
1 Contains 18.18% crude protein (CP), 15.10% lysine (Lys), 
1.60% crude fiber (CF), minimum 3.5% calcium (Ca), 
maximum 4.50% calcium (Ca), 59.99 parts per million (ppm) 
selenium (Se), 18,814 ppm zinc (Zn), 63,750 phytase activity 
(FTU/Ib) phytase. 
2 Average of all 4 repetitions. 
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Table 3.2. Feed Analysis of sow supplemental diets by dietary treatment groups 
 CON 
Supplement2 
BEEF 
Supplement3 
SUGAR 
Supplement4 
B+S 
Supplement5  
Ingredients      
Dry Matter (DM) % 89.33 99.15 99.6 -- 
Carbohydrates, % of 
DM1 
58.73 0.11 100.0 
50.11 
Ash, % of DM 5.70 3.35 0.00 1.67 
Crude Protein, % of DM 13.46 48.67 0.00 24.33 
Total Dietary Fiber, % of 
DM 
18.42 0.00 0.00 
0.00 
Ether Extract, % of DM 3.69 47.87 0.00 23.93 
Calcium, % of DM 0.71 0.01 0.00 0.005 
Phosphorus, % of DM 0.74 0.42 0.00 0.21 
1 DM= Dry Matter. 
2 CON = control supplement; 126 g corn-soybean meal, n= 5. 
3 BEEF = cooked ground beef supplement; 110 g, n = 6. 
4 SUGAR = granulated sugar supplement; 85.5 g, n = 5. 
5 B+S = half cooked ground beef (54.8 g) and half granulated sugar (42.7 g); n = 5.  
 
Once farrowing was completed, farrowing date, sex, birth weight, and teat count were 
recorded. Piglets were ear notched for identification and needle teeth clipped. On d 2 post-
farrowing, piglets had their tails docked and were given 1 cc each of iron and Duramycin 
(Durvet, Blue Springs, MO) intramuscularly on opposite sides of the neck. Because this project 
was biomedical in nature, male piglets were not castrated at this time. In addition to birth weight, 
piglet body weights were recorded on d 6, 12, and 18 (weaning). At weaning, piglets were given 
1 cc of Bo-Se (Merk Animal Health, Kenliworth, NJ) and 2 cc of RhiniShield TX4 (Norvartis, 
Basel, Switzerland) intramuscularly on opposite sides of the neck. One week post-weaning, 
piglets were given 1 cc each of MycoFlex (Boehringer Ingelheim, Ingelheim am Rhein, 
Germany) and CircoFlex (Boehringer Ingelheim) intramuscularly on opposite sides of the neck. 
The median weight male and female from each litter was selected for use in this study. 
Piglets were housed individually, given ad libitum access to water, and fed for ad libitum 
intake twice daily at 0700 and 1500 with a phase feeding system. Nursery phase 1 was fed from 
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d 18 to 22, nursery phase 2 from d 23 to d 38, nursery phase 3 from d 39 to d 59, grower phase 1 
from d 60 to d 97, grower phase 2 from d 98 to d 138, and the finishing phase from d 139 to 
approximately d 167 ± 12 (Table 3.3). 
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Table 3.3. Diet and nutrient composition of offspring diets5 
 Nursery Phase 1 Nursery Phase 2 Nursery Phase 3 Grower Phase 1 Grower Phase 2 Finishing Phase1  
Ingredient, % of DM       
Corn 28.8 52.42 70.48 76.71 81.38 84.60 
Soybean Meal 16.2 23.9 26.4 20.7 16.5 13.55 
MonoCal -- 0.55 0.72 0.47 0.22 0.095 
Limestone -- 0.67 1.06 0.95 0.89 0.86 
Fat, CWG -- 1.50 -- -- -- -- 
Salt -- 0.40 0.45 0.40 0.40 0.40 
EnMax Sow Premix 101 -- 0.30 0.25 -- -- -- 
EnMax Ralco Starter Nursery Base 
11002 
55 20 -- -- -- -- 
EnMax GF Premix 7.53 -- -- 0.19 0.37 0.37 0.37 
L-Lys -- 0.15 0.26 0.25 0.20 0.11 
L-thr -- 0.045 0.08 0.065 0.025 -- 
Dl-meth -- .007 0.11 0.075 0.01 -- 
Nutrient Analysis4       
Dry Matter (DM), % 90.88 90.59 89.99 88.31 88.03 87.73 
Carbohydrates, % of DM 53.55 55.49 60.20 63.68 65.49 67.22 
Ash, % of DM 7.95 6.62 5.40 4.55 4.09 3.90 
Crude Protein, % of DM 23.09 21.35 19.75 17.57 16.38 14.72 
Total Dietary Fiber, % of DM 10.12 11.24 11.77 11.18 10.93 11.12 
Ether Extract, % of DM 5.29 5.30 2.89 3.05 3.11 3.03 
Calcium, % of DM 0.96 0.89 0.75 0.60 0.54 0.56 
Phosphorus, % of DM 0.76 0.69 0.56 0.53 0.43 0.39 
1 Contains 18.18% crude protein (CP), 15.10% lysine (Lys), 1.60% crude fiber (CF), minimum 3.5% calcium (Ca), maximum 4.50% calcium (Ca), 59.99 
parts per million (ppm) selenium (Se), 18,814 ppm zinc (Zn), and 63,750 phytase activity (FTU/Ib) phytase. 
2 Contains minimum 19.70% crude protein (CP), minimum 1.65% lysine (Lys), minimum 5.60% crude fat (Fat), maximum 2.00% crude fiber (CF), minimum 
0.90% calcium (Ca), maximum 1.40% calcium (Ca), minimum 0.70% phosphorus (P), minimum 1.00% salt (NaCl), maximum 1.50% salt (NaCl), minimum 
0.40% sodium (Na), maximum 0.90% sodium (Na), minimum 0.54 parts per million selenium (Se), minimum 5,221 parts per million zinc (Zn), and minimum 
1,000 FTU/lb Phytase.  
3 Contains minimum 25.21% crude protein (CP), minimum 20.55% lysine (Lys), maximum 1.30% crude fiber (CF), minimum 0.90% calcium (Ca), maximum 
1.40% calcium (Ca), minimum 79.99 parts per million selenium (Se), minimum 22,990 parts per million zinc (Zn), and minimum 59,650 FTU/lb phytase.  
4 Average of all 4 repetitions. 
5 Nursery phase 1 fed from d 18 to d 22 of age, Nursery phase 2 fed d 23 to d 38 of age, Nursery phase 3 fed d 39 to d 59 of age, Grower phase 1 fed d 60 to d 
97 of age , Grower phase 2 fed d 98 to d 138 of age, Finishing phase fed d 139 until tissue collections. 
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Weight, Subcutaneous Fat and Longissimus Dorsi Muscle Area Measurements 
Pigs were weighed on d 28, 42, 56, 70, 84, 98, 112, 126, 140, and 160. Starting on d 84, 
pigs were evaluated for subcutaneous fat (SCF) depth and longissimus dorsi muscle area 
(LDMA) at the 10th rib using an Aloka SSD-500V ultrasound machine fitted with a 3.5-MHz, 
12.5-cm, linear array transducer (Corometrics Medical Systems, Inc., Wallingford, CT). Pigs 
were slaughtered at 160 ± 12 d of age, at which time final 10th rib back fat depth and longissimus 
dorsi muscle area were measured.  
Glucose and Insulin Measurements  
At d 0 and d 2, piglet blood glucose concentration was measured using a ReliOn® Prime 
Blood Glucose Monitoring System (Wal-Mart Stores, Inc., Bentonville, AR). A single drop of 
non-coagulated whole blood was placed on the end of the ReliOn® Prime Blood Glucose Test 
Strip and results were recorded. 
An intravenous glucose tolerance test was performed at 144 ±8 d of age. Pigs were fasted 
from feed for 24 h and water for 12 h prior to the initiation and for the duration of the test. 
Dextrose was infused intravenously at a 0.5 mg/kg of body weight. Blood samples were taken at 
the following time points relative to the time of infusion: -2, 2, 5, 10, 15, 30, 45, 60, 90, 120, and 
180 min. Blood samples were collected from the vena cava using an 18 ga, 4” needle and syringe 
alternating sides of the neck with every blood draw. Blood was immediately transferred into a 
heparin vacutainer and placed on ice until centrifuging. Blood was centrifuged at 4° C, 1500 x g 
for 15 minutes. Plasma was collected off and stored at -20° C. Plasma insulin concentration was 
measured via radioimmunoassay (RIA) using a porcine insulin RIA kit (Cat. # PI-12K, EMD 
Millipore Corporation, St. Louis, MO) at South Dakota State University. 
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Statistical Analysis 
Weights, Subcutaneous Fat, and Longissimus Dorsi Measurements 
Data were analyzed using the mixed procedure in SAS (v. 9.4, SAS Institute, Cary, NC). 
Treatment, sex, repetition, and day/age and treatment by day interaction were fit as fixed effects. 
Other two-way, three-way, and four-way interactions were fit and removed if P < 0.1. A repeated 
statement with pig as the subject was fitted to account for repeated measures on the individual 
pigs. Because SAS will not allow 2 repeated statements and sow was the experimental unit, sow 
nested within repetition was fit as a random effect. Different covariance structures were tested 
for both the repeated statement and sow nested within repetition random effect. The best fit 
covariance structure based on Akaike Information Criterion was chosen. Because there were 
some sows used across repetitions, sow not nested within repetition was also fit as a random 
effect. 
Glucose Measurements 
Day 0 and d 2 blood glucose concentrations, data were analyzed using the mixed 
procedure in SAS. Sex, repetition, treatment, and day were fit as fixed effects. Two-, three-, and 
four-way interactions were fit and removed from the model if P > 0.10. A repeated statement 
was fit with pig as the subject and different covariance structures were tested, with the best fit 
being chosen using AIC and BIC. Because sow was the experimental unit for treatment, sow 
nested within repetition was fit as a random effect and different covariance structures were 
tested, with the best fit being chosen using AIC and BIC. Normally, the default covariance 
structure for a random effect would be used; however, in this case, sow nested within repetition 
was a second repeated measures subject and SAS would not run with two repeated statements 
(one with pig as the subject and one with sow nested within repetition as the subject). 
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Additionally, due to the 3 sows repeated across repetitions, sow not nested within repetition was 
fit as a random effect.  
Insulin Measurements 
Plasma insulin concentrations were analyzed using both area under the curve and a 
repeated measures analysis. For area under the curve, SAS Macro code developed by Shiang 
(2004) was used to calculate Total Area Under the Curve (TAUC), Net Area Under the Curve 
(NAUC), and Positive Area Under the Curve (PAUC), utilizing the trapezoidal rule for 
calculating area under a curve. Once TAUC, NAUC, and PAUC was calculated for each pig, 
TAUC, NAUC, and PAUC were analyzed using the mixed procedure of SAS. Fixed effects 
included were treatment, repetition, and sex. The two- and three-way interactions were fit and 
removed from the model if P > 0.10. Because treatment was assigned to the sow, a repeated 
measure was fit with sow nested within repetition as the subject. Different covariance structures 
for the repeated statement were tested and the best fit based on Akaike information criterion 
(AIC) and Bayesian information criterion (BIC).  Because 3 sows were duplicated across 
repetitions, sow not nested within repetition was fit as a random effect. For insulin analyzed as a 
repeated measure, insulin concentrations were analyzed using the mixed procedure in SAS, with 
fixed effects of treatment, time, repetition, and sex. Two-, three-, and four-way interactions were 
fit and removed from the model if P > 0.10. A repeated statement was fit with pig as the subject 
and different covariance structures were tested, with the best fit being chosen using AIC and 
BIC. Because sow was the experimental unit for treatment, sow nested within repetition was fit 
as a random effect and different covariance structures were tested, with the best fit being chosen 
using AIC and BIC. Normally, the default covariance structure for a random effect would be 
used; however, in this case, sow nested within repetition was a second repeated measures subject 
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and SAS would not run with two repeated statements (one with pig as the subject and one with 
sow nested within repetition as the subject). Additionally, due to the 3 sows repeated across 
repetitions, sow not nested within repetition was fit as a random effect. 
Results 
Offspring Body Weight 
Offspring body weight (BW) was measured every 6 days until weaning and then every 14 
days post weaning. Both sex and sex by day interaction had a significant effect on BW, a P-value 
of 0.003 and <0.0001, respectively (Table 3.4). The treatment by day interaction was trending 
with a P = 0.09, while treatment alone was not significant with a P = 0.55. Looking further into 
the sex by day interaction significance differences between males and females starts at d 112 and 
continues until d 160 (Table 3.6). The same trend can be seen in Table 3.5 with BW by treatment 
and day interaction. On d 112 (P = 0.0005) there is a difference between the BEEF (83.37 ± 1.80 
kg) and SUGAR (80.00 ± 1.80 kg) supplements that continues until day 140 (P < 0.0001), by d 
160 (P < 0.0001) of age BEEF (123.98 ± 1.92 kg) and B+S (119.77 ± 1.92 kg) supplements 
differ, along with CON (126.18 ± 1.92 kg) differing from all other treatments. 
Table 3.4. The effect of treatment, sex, and their interaction on offspring growth and carcass 
traits.1 
 Treatment  Sex  P-values 
Trait3 BEEF SUG B+S CON  Female Male SED3 Trt Sex Trt*Sex Sex*Day Trt*Day 
SCF 0.813 0.779 0.819 0.823  0.809 0.809 0.012 0.29 0.99 0.18 0.01 0.66 
LDMA 20.79 20.74 19.92 20.16  20.21 20.60 0.27 0.49 0.17 0.001 0.96 0.80 
BW 46.20 44.67 45.58 45.82  44.37a 46.77b 0.51 0.55 0.0006 0.36 <0.0001 0.09 
1SCF = Subcutaneous fat, LDMA = longissimus dorsi muscle area, BW = body weight, SUG = sugar supplement, B+S = beef 
and sugar supplement, CON = control supplement, Trt = treatment. 
2SED = maximum standard error of the difference 
3SCF and LDMA measured in cm, BW measured in kg  
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Table 3.5. The effect of treatment by day interaction on body weight (kgs).  
Day BEEF SUGAR B+S1 CON1 P-value SED1 
0 1.81 1.70 1.78 1.89 0.91 1.80 
6 2.68 2.60 2.52 2.96 0.80 1.80 
12 4.15 4.16 4.09 4.53 0.80 1.80 
18 5.70 6.00 5.69 6.29 0.73 1.80 
28 8.07 7.86 7.88 8.41 0.73 1.80 
42 15.58 15.43 15.45 16.11 0.67 1.80 
56 26.60 26.32 27.33 26.74 0.56 1.80 
70 40.74 39.26 41.20 39.09 0.24 1.80 
84 54.23 51.95 54.05 52.61 0.15 1.80 
98 70.48 67.67 69.53 68.31 0.08 1.80 
112 83.37a 80.00b 82.05ab 81.38ab 0.03 1.84 
126 98.58a 93.50b 97.16a 96.63ab 0.002 1.84 
140 110.88a 106.91b 109.70ab 110.39a 0.014 1.87 
160 123.98a 122.11ab 119.77b 126.18c 0.001 1.92 
1SED = maximum standard error of the difference within day, B+S = beef and sugar 
supplement, CON = control supplement. 
a,bMeans with differing superscripts within a row differ by P < 0.05. 
 
Table 3.6. The effect of sex by day interaction on body weight (kgs). 
Day Female Male P-value SED1 
0 1.83 1.75 0.94 1.07 
6 2.73 2.65 0.94 1.07 
12 4.29 4.17 0.91 1.07 
18 6.04 5.80 0.82 1.07 
28 8.09 8.02 0.95 1.07 
42 15.53 15.75 0.83 1.07 
56 26.42 27.06 0.54 1.07 
70 39.88 40.26 0.72 1.07 
84 53.04 53.38 0.75 1.07 
98 68.08 69.92 0.08 1.07 
112 79.79 83.60 0.0005 1.08 
126 93.00 99.93 <0.0001 1.08 
140 104.90 114.04 <0.0001 1.08 
160 117.53 128.49 <0.0001 1.14 
1SED = standard error of the difference within day. 
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Offspring Subcutaneous Fat Measurements  
For SCF, sex by day interaction was significant (P = 0.01), while treatment, sex, and 
treatment by day were not significant (P > 0.05, Table 3.4). On d 140 males (2.48 ± 0.05 cm) had 
significantly greater SCF than females (2.33 ± 0.05 cm) but there was no difference in SCF 
between sex on any of the previous days measured (Table 3.7).  
Table 3.7. The effect of sex by day interaction on subcutaneous fat (cm) measured via 
ultrasound at the 10th rib. 
Day Female Male SED1 
84 1.60 1.54 0.05 
98 1.95 1.92 0.05 
112 2.16 2.06 0.05 
126 2.24 2.29 0.05 
140 2.33a 2.48b 0.05 
1SED = standard error of the difference within day. 
 
Offspring Longissimus Dorsi Muscle Area Measurements 
There was a significant effect of sex by treatment interaction on LDMA (Table 3.4) 
however there was no effect of treatment, sex, or treatment by day (P = 0.40, 0.17, and 0.79, 
respectively, Table 3.4). Female offspring from the SUGAR treatment had greater LDMA than 
females from the other treatments (Table 3.8). Additionally, LDMA was greater in males from 
the BEEF (140.78 ± 3.32 cm2) treatment compared to males form SUGAR (129.55 ± 3.26 cm2) 
and B+S (129.36 ± 4.18 cm2) but not CON (131.71 ± 3.54 cm2) treatments. 
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Table 3.8. The effect of sex by treatment interaction on longissimus dorsi muscle area (cm) 
measured via ultrasound at the 10th rib. 
Treatment BEEF SUGAR B + S CON 
Female 127.46a 138.11bc 127.47a 128.44a 
Male 140.78c 129.55a 129.36ab 131.71abc 
SED1 3.32 3.26 4.18 3.54 
1SED = standard error of the difference within treatment, B+S = beef and 
sugar supplement, CON = control supplement. 
a,bMeans with differing superscripts differ by P < 0.05. 
 
Blood Glucose Concentrations  
Blood glucose concentration was measured on d 0 and d 2 after birth. There were 
significant effects of treatment, day and a treatment by day, with P-values of 0.005, 0.001, and 
0.04 respectively (table 3.9). On both d 0 piglets from the SUGAR treatment had greater blood 
glucose concentration than all other treatments. On d 2 CON had the highest glucose 
concentrations. It can also be seen that BEEF and CON supplements had a significant increase in 
glucose concentrations from d 0 to d 2, while B+S did increase but was not significant. 
Table 3.9. The effects of treatment by day interaction on whole blood glucose (mg/dl).1 
 BEEF SUGAR B+S2 CON2 
Day 0 75.1a 99.2c 76.5a 76.6a 
Day 2 91.2bc 95.9bc 84.7ab 96.3bc 
SED2 4.6 4.5 5.2 4.6 
1P-values: Treatment= 0.005; Day =0.001; Treatment*day = 0.04. 
2 SED = standard error of the difference within treatment, B+S = 
beef and sugar supplement, CON = control supplement.  
abValues within a column with differing superscripts differ by P < 
0.05. 
 
Blood Insulin Concentrations  
There were no significant effects of treatment or sex based on TAUC, PAUC, or NAUC 
(Table 3.10). There was also no significant effect for treatment by time interaction of plasma 
insulin concentration (P = 0.14). There was a significant effect of time on insulin concentration 
(P <0.0001, Figure 3.1). When looking at insulin levels by sex there was a significant effect of 
time (P = <0.0001) and the interaction of sex by time was trending with a P = 0.07 (Figure 3.2). 
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The differences fall at the time of insulin spike of 15 and 30 minutes. There was also a 
significant treatment by sex interaction of insulin levels (P = 0.0002, Table 3.11). It can be seen 
that males have greater insulin concentration and specifically the CON male (18.12 ± 1.98) has 
the greatest insulin levels, with both male (10.43 ± 2.43) and female (9.29 ± 2.30) B+S having 
the lowest insulin levels.  
Table 3.10. The effects of treatment and sex on insulin using total, net, and positive area under 
the curve. 
 BEEF SUGAR B+S1 CON1 P-value SED2 Female Male P-value SED2 
Sex*Trt 
(P-value) 
TAUC1 2185  1830  1903  2342  0.22 302 1936 2193 0.17 245 0.80 
NAUC1 894  646  484  1248  0.25 397 735 901 0.53 213 0.49 
PAUC1 974  676  526  1298  0.19  372 833 904 0.76 199 0.68 
1TAUC = total area under the curve; NAUC = net area under the curve; PAUC = positive area under the curve; B+S = beef 
and sugar supplement; CON = control supplement. 
2 SED = standard error of the difference within treatment. 
 
Table 3.11. The effects of treatment by sex interaction on insulin concentrations (µU/mL)1. 
 BEEF SUGAR B + S2 CON2 
Female 13.84ab 11.50a 9.30a 11.65a 
Male 15.27ab 12.29a 10.44a 18.12b 
SED2 1.92 1.84 2.43 1.98 
1P-values: Treatment = 0.20; Sex = 0.14; 
Treatment*sex = 0.0002. 
2 SED = standard error of the difference within 
treatment, B+S = beef and sugar supplement, CON = 
control supplement. 
ab Values with differing superscripts differ by P < 0.05. 
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Figure 3.1. The effect of maternal diet on offspring plasma insulin following intravenous 
glucose infusion (0.5 g/ kg body weight) where time is minutes after infusion. Error bars depict 
the standard error of the difference. P-values: treatment = 0.20, time = <0.0001, treatment*time 
= 0.14. 
 
Figure 3.2. The effect of maternal diet on offspring plasma insulin by sex following intravenous 
glucose infusion (0.5 g/ kg body weight) where time is minutes after infusion. Error bars depict 
the standard error of the difference. P-values: sex = 0.14, time = <0.0001, sex*time = 0.07. ab 
time points with male and female differ by P <0.05. 
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Discussion 
Offspring Body Weight, Subcutaneous Fat, and Longissimus Dorsi Muscle Area 
For BW and SCF traits, offspring sex had a significant effect, while supplemental 
treatments generally were trending or not significant. Longissimus dorsi muscle area had a sex 
by treatment affect while the other traits depended on age.  The different effects of these trait 
based on sex most likely is the result of the different male and female sex hormones stimulate 
metabolism and growth (Sheikh et al., 2017). Campbell et al., (1989) reported that boars, gilts, 
and barrows all starting at approximately 61 kgs BW finished at 97.8, 91.8, and 93.7 kgs 
respectively. It can also be seen by Bratzler et al., (1954), that different levels of circulating 
testosterone have effects on growth with barrows finishing at 99.6 kg and boars at 101.7 kg. Sex 
characteristics also influence SCF and LDMA. When looking at a finishing weight of 
approximately 95 kgs, Cahil et al., (1960) reported that barrows had the most SCF thickness 
compared to gilts and boars. It was also reported by Christian et al., (1980) that SCF was thicker 
in barrows compared to gilts. As for LDMA it was seen that gilts have a larger muscle size then 
males (Christian et al., 1980). The results from Christian et al., are similar with the current 
projects SUGAR supplement, as LDMA of females with this treatment have the second highest 
LDMA. A reason for this difference could be due to gilts generally having leaner carcasses 
(Cahill et al., 1960).  
A study conducted by Long et al., (2010) investigated maternal over nutrition in sheep 
and its effects on offspring weight. Researchers reported that at birth there was no significant 
difference between the control and the over fed dam’s offspring (Long et al., 2010). That study 
along with another study reported by Bayol et al. (2005) that also saw no differences among 
treatment group offspring supports our findings in this current study, as treatment applied to the 
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mother did not affect birth weights. An interesting find between the two previously mentioned 
studies was that postnatal growth until harvest was not affected, which was also similar in this 
study as treatment by day was only considered to be trending (Bayol et al., 2005; Long et al., 
2010). Bayol et al., (2005) also reported increased perineal fat in offspring whose mothers 
consumed a high sugar diet in gestation and lactation. The results from Bayol et al., (2005) were 
different from this study as treatment did not have a significant effect but sex did as previously 
mentioned. Reasons for this could be due to sows not receiving enough sugar to cause increased 
fat disposition in their offspring. It has also been reported that increased protein supplementation 
increases BW, and muscling. A study conducted by Hale and Southwell (1967) saw that pigs 
supplemented protein at different levels saw an increase in LDMA with an increase in protein 
provided. Results from Hale and Southwell (1967) are similar with our findings that males 
supplemented BEEF had the largest LDMA. 
Blood Glucose Concentration  
Sows continued to receive supplement treatments during lactation, therefore it is possible 
that the milk from SUGAR sows had greater glucose concentration than the other treatments, 
resulting in the observed differences in piglet blood glucose concentration. It can also be seen 
that within treatment, with the exception of SUGAR, d 2 was greater than d 0. The reason that 
SUGAR did not increase from d 0 to d 2 could be due to the fact that on d 0 it was already raised 
to a high level and was starting to level out. This is most likely due to the fact that glucose levels 
reach adult levels 2-3 days after birth (Canadian Paediatric Society, 2004). It is reported that 
human infants normal level of glucose 2 hours after birth is approximately 36 mg/dl and will rise 
to over 54 mg/dl after about 2-3 days (Canadian Peadiatric Society, 2004). The normal blood 
glucose level for an adult Yorkshire pig is 60 mg/dl, allowing comparisons to be made (Bellinger 
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et al., 2006). Adult swine concentrations are slightly higher than the reported human 
concentrations. Since all piglets based on both sex and treatment in this current study had raised 
levels compared to human levels could indicate that all animals used in this study were affected 
by hyperglycemia during the initial days following birth.  
Blood Insulin Concentration 
An intravenous glucose tolerance test was performed at approximately 5 months of age 
on the offspring. It was seen that numerically males were higher in all the treatments by sex 
interaction when compared to the female’s insulin levels. This could be attributed to the 
differences in sex hormones. It has been reported that estrogen, which is higher in females, plays 
a role on insulin sensitivity even with women generally having greater adiposity than men (Geer 
and Shen, 2009). It was also reported by Geer and Shen (2009) that when men had a lack of 
estrogen activity, insulin resistance would increase. Suggesting that since women have higher 
levels of estrogen there is increased insulin sensitivity, leaving males who have lower estrogen 
levels to have decreased insulin sensitivity and the possibility to become more insulin resistant 
when compared to females. These findings could be a factor as why we observed greater insulin 
levels in males compared to the females in this current study. Another interesting point is that 
CON males had the overall highest insulin levels, while B+S was the lowest for both genders. 
We hypothesized that the offspring from the SUGAR treatment would be the most likely to 
develop insulin resistance later in life, but this was not the case as both CON and BEEF offspring 
have greater insulin concentrations, which could lead to insulin resistance and diabetes. A study 
conducted by Nivoit et al. (2009) fed pregnant rats a high-sugar diet and a normal rat chow diet, 
at 10 months of age they observed that males had greater insulin concentrations compared to the 
females, which was similar to what was seen in this study. However, researchers also saw that 
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the male offspring from the high-sugar diet mothers also had an increase in insulin 
concentrations which, was not seen in this current study.  
It can be seen in most of the characteristics analyzed from this study that there were sex 
effects, with treatment only affecting LDMA and insulin concentrations. This could be due to the 
time supplemental feeding was started, missing the first 30 days of gestation (Ravelli et al., 
1999). Another aspect could be that the supplement treatments mothers were given were not fed 
in large enough quantities to induce developmental programming of insulin resistance or obesity. 
For example, the average American women consumes 111 g of sugar daily and weights 
approximately 76.4 kg, bringing her average daily intake of sugar to 1.45 g per kg body weighs 
(Fryar et al., 2016; NHANES, 2017). Where as the sows in this experiment on the SUGAR 
supplement consumed 1.15 g of sugar per kg of body weight daily, a lower level than the average 
American. The BW of the offspring at 5.5 months of age, which is typical slaughter age of pigs, 
was within the range of typical slaughter weight, approximately 127.2 kg, for market pigs, 
indicating that they were not obese (Pork checkoff, 2017).  
Conclusion  
Our hypothesis was that substituting beef for the high levels of sugar found in a typical 
North American diet during pregnancy would reduce developmental programing of obesity and 
insulin resistance in the offspring. The treatments may have been too conservative to induce 
obesity and diabetes in the offspring, however the differential sex effects of treatment on LDMA 
and insulin concentration is promising and warrants further investigation into the replacement of 
sugar for beef during pregnancy. 
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CHAPTER 4: CONCLUSION 
The objective of this research was to investigate if consuming supplemental beef instead 
of sugar during pregnancy would mitigate the negative effects of a typical North American high 
sugar diet on offspring growth and development. This study was conducted to provide pregnant 
women with recommendations on healthier dietary options to replace sugar in their diet and 
benefit their offspring. The results from this project showed that individuals whose mothers 
consumed the beef diet had greater expression in genes related to diabetes compared to those 
who consumed sugar. With seeing these results, the individuals who had decreased expression 
had the potential to be more prone to developing metabolic issues later in life. Swine were used 
in this study because of their similar growth and development to humans, along with having 
similar disease progression. Using swine as a model was also beneficial in the fact that they have 
large liter size, allowing researchers to investigate treatment effects on full siblings.  
It was seen in the fetal study that sugar supplement did have an effect on IGF2, IGF2R 
and FBPase expression, with expression being down regulated in all three genes. At this time the 
potential underlying epigenetic effects that caused these three genes to shift is unknown and 
further research would need to be conducted. With the offspring study, differences were seen 
when comparing beef and control supplements to the sugar and beef + sugar diet, but there were 
generally no differences between beef and control treatment groups. Beef treatment resulted in 
increased longissimus dorsi muscle area. It was also seen that in both beef and control 
supplements insulin levels in the males were increased. As for females they did not differ among 
themselves based on treatment but males across all treatments had increased fasting insulin 
levels when compared to females. This relationship generally had to do with the sex hormone 
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estrogen. Estrogen is thought to play a role in insulin sensitivity, since males generally have less 
they tend to become more prone to insulin resistance later in life.  
The fetal and offspring studies conducted simultaneously with the end goal of seeing how 
the supplemental treatments would affect in-utero development and offspring overall growth. It 
can be seen in these studies that the fetuses whose mothers consumed added sugar during 
pregnancy had decreased expression in genes related to glucose homeostasis, suggesting that 
they would have insulin resistance during their life time. This thought can be demonstrated with 
the whole blood glucose levels that were seen on d 0 and d 2 in the offspring born to mothers on 
the sugar supplement. Their glucose levels were significantly raised compared to the other 
treatments, leading us to believe that these fetuses and offspring had insulin resistance during 
gestation and after birth.  
Since carcass characteristics were investigated and there was an increase in longissimus 
dorsi muscle area on the beef treated offspring, it brings in to question if this is something that 
could also benefit producers? First, feed cost is generally the largest cost of production, so 
adding in beef to the diet may not be profitable for the average farmer to do. They could however 
find a less expensive source of protein to add and possibly see the same effects  
To truly understand the underlying mechanisms affected by sugar intake more studies of 
this nature need to be investigated with increased amounts of sugar consumption compared to 
what was used in this study. Additionally, further study needs to be conducted with 
implementation of the treatments in early pregnancy and even prior to conception. That is a step 
that was not taken in this study due to the risk of pregnancy loss.  
From this study it is possible that in the fetal study that the treatments had the potential to 
have significant effects if treatment amounts were increased. From the offspring study it was 
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determined that supplemental beef did an cause increase in size and muscling on longissimus 
dorsi area but with the sugar diet may have been to conservative and further research would need 
to be conducted to accurately make suggestions to the diet of pregnant women.  
 
